
<!DOCTYPE html>
<html dir="ltr" lang="en">
<head>
 
<link rel="preconnect" href="https://cdn.cookielaw.org">
<link href="https://cdn.cookielaw.org/scripttemplates/otSDKStub.js" rel="preload" as="script">
 <link href="https://www.googletagmanager.com/gtm.js?id=GTM-5MKXR9" rel="preload" as="script">
<!-- OneTrust Cookies Consent Notice start --> 
<script src="" type="text/javascript" charset="UTF-8" data-domain-script="7a4eae6f-1f57-4f7c-8a64-5aa159ee745e"></script>
<script type="text/javascript">
function OptanonWrapper() { }
</script>
<!-- OneTrust Cookies Consent Notice end -->
<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1">
<meta lang="en">
<meta http-equiv="content-type" content="text/html; charset=utf-8">
<meta http-equiv="content-language" content="en">
<meta name="viewport" content="width=device-width, height=device-height, initial-scale=1, minimum-scale=1, maximum-scale=5, user-scalable=1">
 <!-- Title and Description -->
 <title>Medications for Deep Venous Thrombosis - Cardiovascular Disorders - MSD Manual Professional Edition</title>
 
 <!-- Schema.org/Additional markup -->
 
 
 
 
 
 
 
 
 
 
 
 
 
 <!-- Twitter Card data -->
 
 
 
 
 
 <!-- Open Graph data -->
 
 
 
 
 
 
 
 
 
 
 
 
 
<!-- Google Tag Manager --> <script></script> <!-- End Google Tag Manager -->
 <script type="text/javascript">
 // Way froward settings. Strongly typed for Typescript code.
 // Typescript definition file is in \src\Foundation\Presentation\code\Scripts\typings\Settings.d.ts
 MManual = window.MManual || {};
 MManual.Foundation = MManual.Foundation || {};
 MManual.Feature = MManual.Feature || {};
 MManual.Foundation.Logging = {
 Level : "WARN"
 }
 MManual.Foundation.Context = {
 Language: {
 Name: "en",
 Code: "en"
 },
 Edition: "Professional"
 }
 MManual.Foundation.Context.Item = {}
 
 MManual.Foundation.Context.Item.SitecoreId = "99f36709-190d-404e-bf6d-a0b1f6a706f0";
 MManual.Foundation.Context.Item.MediaId = "";
 MManual.Foundation.Context.Item.VasontId = "v45392015";
 MManual.Foundation.Context.Item.TemplateId = "9fe4ab09-1603-40e4-91f9-0ac01a474c58";
 
 
 MManual.Foundation.Context.Chapter = {
 SitecoreId : "0963b4ac-9b4f-4fc9-915a-21ee43bb9a88",
 VasontId : "v940893"
 }
 MManual.Foundation.Context.Section = {
 SitecoreId : "ee8ab93f-6fdb-4525-b9c2-55a87a4f1a0c",
 VasontId : "v878834"
 }
 
 MManual.Foundation.TemplateIds = {
 Topic : "9fe4ab09-1603-40e4-91f9-0ac01a474c58"
 }
 MManual.deferredScripts = [];
 // Below settings are obsolete. Please use MManual.Foundation.Context
 //////////////////
 // OBSOLETE START
 ///////////////////
 MManual.settings = MManual.settings || {};
 MManual.settings.edition = "Professional";
 MManual.settings.language = "en";
 MManual.settings.languageCode = "en";
 MManual.settings.displayDateFormat = "dd/MM/yy";
 MManual.settings.dateFormat = "dd/MM/yy";
 MManual.settings.loadLocationsGlobal = true;
 MManual.settings.LexicompEnabled = false;
 MManual.settings.topic = MManual.settings.topic || {};
 MManual.settings.topic.getTopicsForResourceUrl = "/Redesign/Topic/GetTopicsForResource";
 MManual.settings.topic.getTopicHelpfulUrl = "/Redesign/Topic/GetTopicHelpful";
 MManual.settings.topic.wasThisTopicHelpfulUrl = "/Redesign/Topic/WasThisTopicHelpful";
 MManual.settings.topic.getTableBodyUrl = "/Redesign/Topic/GetTableBody";
 MManual.settings.socialMedia = MManual.settings.socialMedia || {};
 MManual.settings.socialMedia.enableMultimediaPopupShareButton = true;
 MManual.CommonLetters = ['A', 'B', 'C', 'D', 'E', 'F', 'G', 'H', 'I', 'J', 'K', 'L', 'M', 'N', 'O', 'P', 'Q', 'R', 'S', 'T', 'U', 'V', 'W', 'X', 'Y', 'Z'];
 MManual.CommonNumbers = ['0', '1', '2', '3', '4', '5', '6', '7', '8', '9'];
 MManual.Context = MManual.settings;
 MManual.Context.Item = MManual.Foundation.Context.Item;
 /////////////////
 // OBSOLETE END
 /////////////////
 </script>
 <script src="./Content/Scripts/Redesign/Lib/jquery-3.5.1.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/jquery-ui-1.13.1.custom/jquery-ui.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Foundation/Presentation/Library/Knockout/knockout-3.5.1.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/hammer.2.0.7.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/polyfills/es5-shim.4.5.13.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/polyfills/es6-shim.0.35.4.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/slick-1.8.0/slick.1.8.0.min.js" type="text/javascript"></script>
<!--[if (gte IE 9)|!(IE)]><!-->
<script src="./bundles/redesign/libsjsv4.1.2.2-13178e13ca.js?v=9oeWsccS0AXvU_mpLneFQpk81D2qyviYAadBAspEdRc1"></script>
<!--<![endif]-->
<!--[if lt IE 9]>
 <script src="/bundles/redesign/ie8libsjsv4.1.2.2-13178e13ca.js?v=NYMKNIKPtdByxJkp3-a4OoxrVMsYmUh3Th334huO0BY1"></script>
<![endif]-->
<!-- Add custom class to categorize all cookies as functional. -->
<script src='./bundles/redesign/mmanualjsv4.1.2.2-13178e13ca.js?v=qZy1l8ugVchOqoSbrCHnQvB_O3jXnpspHrGZgwDHF0I1' class='optanon-category-C0002'></script>
<script defer="" src='./bundles/redesign/mmanualTopicjsv4.1.2.2-13178e13ca.js?v=kSA_yN8XuMyhoVC1QLzYxWJE66uhmC-mSc_-tgT27II1' class='optanon-category-C0002'></script>
<script defer="" src='./bundles/redesign/mmanualTopicResourceSearchjsv4.1.2.2-13178e13ca.js?v=iHsFLQRu7O1_jYYodP5cLz5m6_oggwQ97PNvPDyRMrw1' class='optanon-category-C0002'></script>
<!--Region information -->
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
<link rel="preload" href="/Content/Fonts/Redesign/oldrambla/Rambla-Latin-webfont.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-700-Bold.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-700-Bold-Italic.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-400-Regular.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-400-Regular-Italic.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-300-Light.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-600-SemiBold.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link href="./bundles/redesign/mmanualcssv4.1.2.2-13178e13ca.css?v=RUczVKOp43QqHlIomZoV4XMWus4DZWBAeuESVt-1iCc1" rel="stylesheet" type="text/css" media="screen">
<link href="./bundles/redesign/jqueryuicssv4.1.2.2-13178e13ca.css?v=3k6hV5TZDiil7_Jv0lADrVVLB9hJfoX2PenhijDq_d81" rel="stylesheet" type="text/css" media="screen">
 <link href="./bundles/redesign/mmanualprofessionalcssv4.1.2.2-13178e13ca.css?v=mbUz3b7WGmUBumHpYEaEcWfHb1bxVAgvrA5uGMAlaJ81" rel="stylesheet" type="text/css">
<!--[if lt IE 9]><link href="/bundles/redesign/ie8cssv4.1.2.2-13178e13ca.css?v=" rel="stylesheet"/>
<![endif]-->
<link href="./bundles/redesign/mmanualcssprintv4.1.2.2-13178e13ca.css?v=2xJ7o27xwBLBtbGx65XzwLYcjgNEMec7qcBRi3GYAM01" rel="stylesheet" type="text/css" media="print">
<link href="./bundles/redesign/mmanualcsshybridv4.1.2.2-13178e13ca.css?v=LCUeOfwqiGi437ffhbWXxV6YW74rb9NUl93CESRStCs1" rel="stylesheet" type="text/css" media="hybrid">
<!--[if lt IE 9]>
 <script src="//html5shiv.googlecode.com/svn/trunk/html5.js"></script>
<![endif]-->
<script type="text/javascript">
 function msieversion() {
 var ua = window.navigator.userAgent;
 var msie = ua.indexOf("MSIE ");
 if (msie > 0 || !!navigator.userAgent.match(/Trident.*rv\:11\./) || msie == NaN)
 var test = $('li.no-children');
 test.addClass("noSpace");
 return false;
 };
 //msieversion();
</script>
<div style="display: none">
 <div class="confirmationpopup__container" id="access-confirmation-popup" style="z-index: 10000;">
 <div>
 <div>
 <div>
 <div class="confirmationpopup__container">
 <span class="confirmationpopup__logo"></span>
 <div class="confirmationpopup__title">
 <span class="confirmationpopup__text">MSD Manual</span>
 </div>
 <div class="confirmationpopup__description">
 <p>Please confirm that you are a health care professional</p>
 </div>
 <div class="confirmationpopup__answer">
 <a class="confirmationpopup__button confirmationpopup__button--yes" role="button">Yes</a>
 <a class="confirmationpopup__button confirmationpopup__button--no" role="button">No</a>
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
</div>
<div style="display: none">
 <div class="confirmationpopup__container" id="external-link-confirmation-popup" style="z-index: 10000;">
 <div>
 <div>
 <div>
 <div class="confirmationpopup__container">
 <span class="confirmationpopup__logo"></span>
 <div class="confirmationpopup__title">
 <span class="confirmationpopup__text">Leave this Site?</span>
 </div>
 <div class="confirmationpopup__description">
 <p>The link you have selected will take you to a third-party website. We do not control or have responsibility for the content of any third-party site.</p>
 </div>
 <div class="confirmationpopup__answer">
 <a class="confirmationpopup__button confirmationpopup__button--yes" role="button">Continue </a>
 <a class="confirmationpopup__button confirmationpopup__button--no" role="button">Cancel</a>
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
</div>
 <script> 
 var externalUrls = JSON.parse(atob('["www.cdc.gov/mmwr/preview/mmwrhtml/rr58e324a1.htm","www.cdc.gov/mmwr/preview/mmwrhtml/rr6403a1.htm","www.cdc.gov/vaccines/vpd/hepb/hcp/faqs-hcp-pediarix.html","cid.oxfordjournals.org/content/53/7/e25.full.pdf html?sid=67183860-0d8a-4d54-9d57-fd12d5682421","www.nature.com/articles/s41467-022-32936-3","pubmed.ncbi.nlm.nih.gov/35772465","pubmed.ncbi.nlm.nih.gov/31515408","www.ncbi.nlm.nih.gov/pmc/articles/PMC4028378","www.drugs-porphyria.org","porphyriafoundation.org/drugdatabase","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","aasldpubs.onlinelibrary.wiley.com/doi/pdf/10.1002/hep.31060","academic.oup.com/cid/article/58/1/e1/374007","www.cdc.gov/hepatitis/hav/havfaq.htm","journals.lww.com/ajg/Fulltext/2018/02000/ACG_Clinical_Guideline__Alcoholic_Liver_Disease.9.aspx","www.cdc.gov/mmwr/preview/mmwrhtml/rr6007a1.htm","jama.jamanetwork.com/article.aspx?articleid=2492881","www.nhlbi.nih.gov/health-pro/guidelines/current/cardiovascular-health-pediatric-guidelines","gi.org/guideline/genetic-testing-and-management-of-hereditary-gastrointestinal-cancer-syndromes","rheumatology.oxfordjournals.org/content/42/2/235.full.pdf","onlinelibrary.wiley.com/doi/10.1002/14651858.CD003448.pub4/abstract?systemMessage=Wiley Online Library will be unavailable on Saturday 17th December 2016 at 09:00 GMT/ 04:00 EST/ 17:00 SGT for 4hrs due to essential maintenance.Apologies for the inconvenience","cid.oxfordjournals.org/content/early/2016/11/03/cid.ciw670.full","www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm","onlinelibrary.wiley.com/doi/10.1111/apt.13148/abstract","onlinelibrary.wiley.com/doi/10.1359/jbmr.06s204/abstract","onlinelibrary.wiley.com/doi/10.1002/jbmr.438/abstract","journals.lww.com/infectdis/Fulltext/2013/05000/New_Guidelines_for_Antimicrobial_Prophylaxis_in.10.aspx","jama.jamanetwork.com/article.aspx?articleid=1487498","cid.oxfordjournals.org/content/46/12/1801.full","www.cdc.gov/mmwr/volumes/67/wr/mm6703a5.htm","www.cdc.gov/mmwr/volumes/68/wr/mm6832a3.htm","www.onlinejacc.org/content/64/22/e77","jamanetwork.com/journals/jamasurgery/fullarticle/2623725","www.cdc.gov/vaccines/hcp/acip-recs/general-recs/timing.html#t-01","www.cdc.gov/mmwr/preview/mmwrhtml/rr5911a1.htm","www.cdc.gov/mmwr/preview/mmwrhtml/rr5604a1.htm","www.cdc.gov/vaccines/hcp/acip-recs/general-recs/administration.html","www.cdc.gov/mmwr/volumes/65/rr/rr6503a1.htm","www.onlinejacc.org/content/56/22/1864","www.idsociety.org/practice-guideline/hap_vap","academic.oup.com/cid/article-lookup/doi/10.1086/649858","acp.silverchair-cdn.com/acp/content_public/journal/aim/937814/m183600ff3_panel_2.jpeg?Expires=1556744998&amp;Signature=Oc7aO8PzGrh4tsbJzhWwSTvws~WHIkN~BaNqycHCh1TDufduqpbjgojduPU-8q5Owv2tym0x3HekrEXjegtUiZ2C15Qag5cNuhdxGu84JMb5nLmefg~ofSQfhTAdRWr9ECrJt4a1nu0Rl2crQwlTdDcL4Q8k9MGLgeg6yqGHzJGmlul2E8fEWxiP1ivlR9GypBYLjQ-B3eUH4hi-SYVCDfitv2zjW01hFzUlZM6OSXb5yEGThsimV8yQSCxcSLwaaY~CnZZ96lrcrr87nkPmtyvM9iPUUs-ix3Be5lXTIDWuIRrY3xmWXTnpNu7fxROSemZYm5ESTXbpGdJH6gMyuA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA","www.cdc.gov/mmwr/preview/mmwrhtml/mm6203a3.htm","www.cdc.gov/mmwr/volumes/68/wr/mm6832a3.htm","www.ncbi.nlm.nih.gov/pubmed?term=Crit Care Med[Jour] AND 42[volume] AND 1157[page] AND 2014[pdat] AND Karvellas CJ[first author] AND Outcomes and complications of intracranial pressure monitoring in acute liver failure&amp;TransSchema=title&amp;cmd=detailssearch","www.ncbi.nlm.nih.gov/pubmed?term=\"Hepatology (Baltimore, Md.)\"[Jour] AND 66[volume] AND 1219[page] AND 2017[pdat] AND Albillos A[author] AND Stratifying risk in the prevention of recurrent variceal hemorrhage: Results of an individual patient meta-analysis. &amp;TransSchema=title&amp;cmd=detailssearch","fascrs.org/ascrs/media/files/downloads/Clinical Practice Guidelines/the-american-society-of-colon-practical-guideline-sinus-pilonidalis.pdf","fascrs.org/ascrs/media/files/downloads/Clinical Practice Guidelines/practice_parameters_for_the_management_of_hemorrhoids.pdf\"","www.cdc.gov/mmwr/preview/mmwrhtml/mm5803a4.htm","www.cdc.gov/mmwr/volumes/67/wr/mm6722a5.htm","pubmed.ncbi.nlm.nih.gov/21956720-evidence-report-genetic-and-metabolic-testing-on-children-with-global-developmental-delay-report-of-the-quality-standards-subcommittee-of-the-american-academy-of-neurology-and-the-practice-committee-of-the-child-neurology-society?from_term=\"Neurology\"[Jour] AND 2011[pdat]&amp;from_pos=7","www.nal.usda.gov/fnic/vitamins-and-minerals","www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management","www.willseye.org/doctor/melvin-roat-md-facs","faculty.mdanderson.org/profiles/pedro_ramirez.html","pharmacy.ucsf.edu/shalini-lynch","weillcornell.org/jwbarnhill","profiles.stanford.edu/david-spiegel","www.umc.edu/doctors/Huang_Juebin","www.chop.edu/doctors/moldenhauer-julie-s","www.urmc.rochester.edu/people/20996734-stephen-brian-sulkes","podiatry.temple.edu/kendrick-whitney","www.med.upenn.edu/apps/faculty/index.php/g275/p8178541","www.urmc.rochester.edu/people/21136627-ronald-rabinowitz","psychiatry.ubc.ca/person/rosemary-basson","profiles.utsouthwestern.edu/profile/48082/ravindra-sarode.html","sop.washington.edu/people/brian-werth","pharmacy.ucsd.edu/faculty/le","www.chop.edu/doctors/calabria-andrew-c","medicine.uiowa.edu/psychiatry/profile/william-coryell","www.chop.edu/doctors/mehta-jay","www.adelphi.edu/faculty/profiles/profile.php?PID=0649","www.ot.wustl.edu/about/our-people/peggy-barco-8","www.urmc.rochester.edu/people/21411717-jimena-cubillos","www.mlanet.org/resources/userguide.html","www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-vaccine-fact-sheet#how-effective-are-hpv-vaccines","www.ncbi.nlm.nih.gov/books/NBK25349","www.nichd.nih.gov/sites/default/files/2018-09/PRGLAC_Report.pdf","academic.oup.com/cid/article/45/7/941/544359","academic.oup.com/cid/article/55/10/e86/321183","aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.29800","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","www.cdc.gov/hepatitis/hav/havfaq.htm","www.nejm.org/doi/10.1056/NEJMoa1613512?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0www.ncbi.nlm.nih.gov","www.ncbi.nlm.nih.gov/pmc/articles/PMC5848239","pubmed.ncbi.nlm.nih.gov/29260225","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","www.cdc.gov/hepatitis/hav/havfaq.htm","aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.29800","jamanetwork.com/article.aspx?articleid=1487498","www.nejm.org/doi/10.1056/NEJMoa1613512?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0www.ncbi.nlm.nih.gov","circ.ahajournals.org/content/132/15/1435.long","www.porphyriafoundation.com","porphyriafoundation.org/for-healthcare-professionals/drug-safety","www.porphyria-europe.com","www.drugs-porphyria.org","profiles.stanford.edu/judith-prochaska","circ.ahajournals.org/content/132/15/1435.long","aasld.org/publications/practice-guidelines","www.uspreventiveservicestaskforce.org/Page/Topic/recommendation-summary/hepatitis-c-screening","aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.31065","www.ncbi.nlm.nih.gov/pubmed/22972059","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","academic.oup.com/cid/article/53/7/e25/424286","www.idsociety.org/practice-guideline/community-acquired-pneumonia-cap-in-adults","www.idsociety.org/practice-guideline/hap_vap","www.cdc.gov/vaccines/hcp/acip-recs/vacc-specific/pneumo.html","porphyriafoundation.org","www.ncbi.nlm.nih.gov/pmc/articles/PMC4695986","www.lajh.org/about/the-jewish-home-team/meet-our-clinicians","www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html","www.ncbi.nlm.nih.gov/pmc/articles/PMC7431966","www.the-scientist.com/news-opinion/vector-based-vaccines-come-to-the-fore-in-the-covid-19-pandemic-67915","www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32661-1/fulltext","www.med.upenn.edu/apps/faculty/index.php/g275/p8841440","www.cdc.gov/mmwr/volumes/70/rr/rr7001a1.htm","www.essentialaccessibility.com/merck","www.menopause.org/docs/default-source/2017/nams-2017-hormone-therapy-position-statement.pdf","www.ncbi.nlm.nih.gov/pmc/articles/PMC4028378","www.nejm.org/doi/10.1056/NEJMoa2112435?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ajog.org/article/S0002-9378(21)00963-7/fulltext","www.ajog.org/article/S0002-9378(20)30861-9/fulltext","ascopubs.org/doi/full/10.1200/JCO.21.00006","www.nejm.org/doi/10.1056/NEJMoa2112435?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ajog.org/article/S0002-9378(21)00963-7/fulltext","www.thelancet.com/journals/lanonc/article/PIIS1470-2045(19)30020-8/fulltext","ascopubs.org/doi/full/10.1200/JCO.2014.58.3401?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","ascopubs.org/doi/full/10.1200/JCO.2017.76.5966?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ajog.org/article/S0002-9378(20)30861-9/fulltext","www.nejm.org/doi/full/10.1056/NEJMoa1910962?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","jamanetwork.com/journals/jamaoncology/fullarticle/2773114","ascopubs.org/doi/full/10.1200/JCO.21.00006","pubmed.ncbi.nlm.nih.gov/36107786","pubmed.ncbi.nlm.nih.gov/30304427","www.ncbi.nlm.nih.gov/pmc/articles/PMC5958910","www.ahajournals.org/doi/10.1161/HYP.0000000000000084","pubmed.ncbi.nlm.nih.gov/27195814","pubmed.ncbi.nlm.nih.gov/36130612","www.ncbi.nlm.nih.gov/pmc/articles/PMC9940918","pubmed.ncbi.nlm.nih.gov/36351458","pubmed.ncbi.nlm.nih.gov/36041474","pubmed.ncbi.nlm.nih.gov/29608107","pubmed.ncbi.nlm.nih.gov/35316839","pubmed.ncbi.nlm.nih.gov/36148880","pubmed.ncbi.nlm.nih.gov/37295445","www.ncbi.nlm.nih.gov/pmc/articles/PMC7652033","www.nejm.org/doi/10.1056/NEJMoa2032183?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ahajournals.org/doi/full/10.1161/CIR.0000000000000678?rfr_dat=cr_pub  0pubmed&url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org","diabetesjournals.org/care/article/42/1/126/36330/Racial-and-Ethnic-Differences-in-Anthropometric","agsjournals.onlinelibrary.wiley.com/doi/abs","www.ncbi.nlm.nih.gov/pubmed/31515408","opendata.ncats.nih.gov/covid19/variant/activity","opendata.ncats.nih.gov/variant/activity","diabetesjournals.org/care/article/41/12/2669/36544/Management-of-Hyperglycemia-in-Type-2-Diabetes","pubmed.ncbi.nlm.nih.gov/35772465","pubmed.ncbi.nlm.nih.gov/34004177","pubmed.ncbi.nlm.nih.gov/35973577","www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30925-9/fulltext","pubmed.ncbi.nlm.nih.gov/33349658","pubmed.ncbi.nlm.nih.gov/35834240","pubmed.ncbi.nlm.nih.gov/38319329","www.ncbi.nlm.nih.gov/pmc/articles/PMC10752259","pubmed.ncbi.nlm.nih.gov/35449407","pubmed.ncbi.nlm.nih.gov/19502645","pubmed.ncbi.nlm.nih.gov/35483753","pubmed.ncbi.nlm.nih.gov/3404868"]'));
 $(document).ready(function () {
 $("a").click(function() {
 var href = $(this).attr('href');
 if (MManual.Foundation.Url.IsAbsoluteUrl(href)) {
 var hrefWithoutProtocol = MManual.Foundation.Url.RemoveProtocol(href);
 var match = externalUrls.some(function(url) {
 return url.length > 0 && hrefWithoutProtocol.startsWith(url);
 });
 if (match) {
 externalLinkConfirmation.showConfirmationModal(href);
 } else {
 return true;
 }
 } else {
 return true;
 }
 return false;
 });
 });
 </script>
 <!-- AddToAny script remove-->
<script></script>
 
<script type="text/html" id="audio-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__audio hide-on-print">
 <div class="multimedia__audio--wrapper">
 <audio>
 <source data-bind="attr: { src: AudioUrl, type: MimeType }" />
 </audio>
 </div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content">
 <p data-bind="html: Description"></p>
 </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits">
 <p data-bind="html: Credits"></p>
 </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<script type="text/html" id="inlinemedia-audio-template">
 <!-- ko if: isSideline-->
 <div class="inlinebox inlinebox--right inlinebox--clickable" data-bind="attr: {id: ItemId}, css: {'inlinebox--right': !IsInCarousel(), 'inlinebox--full': IsInCarousel}">
 <div class="inlinebox__wrapper">
 <!-- ko ifnot: IsInCarousel-->
 <div class="inlinebox__header">Audio</div>
 <!-- /ko -->
 <div class="inlinebox__content">
 <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: multimediaLinkModel }"></div>
 <div class="inlinebox__button">
 <img loading="lazy" alt="icon" data-bind="attr: {src: ThumbnailUrl}">
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <div data-bind="css: componentClasses(), attr: {id: ItemId}">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 </div>
 <div class="inlinemedia__content">
 <audio>
 <source data-bind="attr: { src: AudioUrl, type: MimeType }" />
 </audio>
 <!-- ko if: detailsAvailable -->
 <div class="inlinemedia__more">
 <div class="inlinemedia__action inlinemedia__action--show" data-bind="event: {click: toggleDetailsFunction, keypress: toggleDetailsFunction}">
 <i class="inlinemedia__eye"></i>
 <span class="inlinemedia__details hide" role="button" tabindex="0">
 Show Details
 </span>
 <span class="inlinemedia__details show" role="button" tabindex="0">
 Hide Details
 </span>
 <div class="inlinemedia__information" data-bind="html: Description"></div>
 <div class="inlinemedia__credits" data-bind="html: Credits"></div>
 </div>
 </div>
 <!-- /ko -->
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
<script type="text/html" id="biodigital-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, iOSresizeIframeToParent : attachResizeCallback, swipe: {next: parentContext.showNext, prev: parentContext.showPrev}" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description" data-bind="getDivRef : $parent.descriptionDivRef">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="inlinemedia-biodigital-template">
 <!-- ko ifnot: isText-->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <!-- ko if: isSideline() && !IsInCarousel() -->
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 <!-- /ko -->
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isSideline -->
 <figure class="box__figure">
 <img oncontextmenu="return false;" loading="lazy" class="box__picture" data-bind="attr: {src: ThumbnailUrl, alt: Title, width:ImageWidth, height:ImageHeight}" />
 <div class="box__action"></div>
 <div class="box__label">3D MODEL</div>
 </figure>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrc, title: Title }"></iframe>
 <!-- /ko -->
 </div>
 <!-- ko ifnot: isInline -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
 
<script type="text/html" id="image-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__image" data-bind="css: zoomClass">
 <div class="multimedia__image--spacer hide-on-print"></div>
 <div class="multimedia__image--wrapper">
 <img oncontextmenu="return false;" loading="lazy" data-bind="attr: { src: ImageUrl, alt: Alt}, getImageDimensions: imageDimensions, pinchZoom: { pinchZoomActive: pinchZoomActive, isZoomed: isZoomed}">
 </div>
 <!-- ko if: zoomEnabled -->
 
 <!-- /ko -->
 <div class="multimedia__image--spacer hide-on-print"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content" data-bind="html: Description"> </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits" data-bind="html: Credits"> </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<script type="text/javascript">
 (function (MManual) {
 var deferredScripts = [];
 
 deferredScripts.push("./bundles/redesign/imageplayerv4.1.2.2-13178e13ca.js?v=sWgoLvG7zFKbYfkOiaTYY5tBk5gefAsRS0qs0ENFdUc1");
 
 MManual.ImagePlayerScripts = deferredScripts;
 }(window.MManual = window.MManual || {}));
</script>
<script type="text/html" id="inlinemedia-photo-template">
 <!-- ko ifnot: isText-->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__innerwrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 </div>
 <div class="inlinemedia__content">
 <div class="inlinemedia__image--container">
 <img class="h-nocopy" loading="lazy" oncontextmenu="return false;" data-bind="attr: { src: ThumbnailUrl, alt: Alt, width:ImageWidth, height:ImageHeight }" />
 </div>
 <!-- ko if: isSideline -->
 <div class="inlinemedia__subtitle" data-bind="html: Credits"></div>
 <!-- /ko -->
 </div>
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isInline() && detailsAvailable() -->
 <div class="inlinemedia__more">
 <div class="inlinemedia__action inlinemedia__action--show" data-bind="event: {click: toggleDetailsFunction, keypress: toggleDetailsFunction}">
 <i class="inlinemedia__eye"></i>
 <span class="inlinemedia__details hide" role="button" tabindex="0">
 Show Details
 </span>
 <span class="inlinemedia__details show" role="button" tabindex="0">
 Hide Details
 </span>
 <div class="inlinemedia__information" data-bind="html: Description"></div>
 <div class="inlinemedia__credits" data-bind="html: Credits"></div>
 </div>
 </div>
 <!-- /ko -->
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
<script type="text/html" id="infographic-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__image" data-bind="css: zoomClass">
 <div class="multimedia__image--spacer hide-on-print"></div>
 <div class="multimedia__image--wrapper h-nocopy">
 <img oncontextmenu="return false;" loading="lazy" data-bind="attr: { src: ImageUrl, alt: Title}, getImageDimensions: imageDimensions, pinchZoom: { pinchZoomActive: pinchZoomActive, isZoomed: isZoomed}">
 </div>
 <!-- ko if: zoomEnabled -->
 <div class="multimedia__image--actions hide-on-print">
 <div class="multimedia__image--actionzoom" data-bind="click: toggleZoom"></div>
 </div>
 <!-- /ko -->
 <div class="multimedia__image--spacer hide-on-print"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: CitationLink -->
 <div class="multimedia__description--source">
 <span class="multimedia__description--sourcetitle">Source:</span>
 <!-- ko if: CitationText -->
 <a href="#" class="multimedia__description--citation" data-bind="text: CitationText, attr: { href: CitationLink }"></a>
 <!-- /ko -->
 <!-- ko ifnot: CitationText -->
 <a href="#" class="multimedia__description--citation" data-bind="text: CitationLink, attr: { href: CitationLink }"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 </div>
 </div>
 </div>
</script>
<script type="text/html" id="inlinemedia-labtest-template">
 <!-- ko if: isSideline -->
 <div class="inlinebox inlinebox--clickable" data-bind="css: {'inlinebox--right': !IsInCarousel(), 'inlinebox--full': IsInCarousel}">
 <div class="inlinebox__wrapper">
 <!-- ko ifnot: IsInCarousel-->
 <div class="inlinebox__header">Lab Test</div>
 <!-- /ko -->
 <div class="inlinebox__content">
 <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: multimediaLinkModel }"></div>
 <div class="inlinebox__button">
 <img class="labtest-icon" loading="lazy" alt="icon" data-bind="attr: {src: ThumbnailUrl }" width="55" height="55" />
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 </div>
 <div class="inlinemedia__content">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="yes" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrc, title: Title }"></iframe>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script><script type="text/html" id="labtest-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper h-ios-iframe-scroll">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="auto" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, setIframePrintTarget: setIframePrintTarget" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">Â«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">â€¹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">â€º</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">Â»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<script type="text/html" id="mediawidget-labtest-template">
 <!-- ko component: {name: 'multimedia-link-text', params: { item: ko.mapping.fromJS({
 ItemId: ItemId,
 IframeSrc: MediaUrl,
 Title: Title,
 ShareUrlTitle: ShareUrlTitle,
 Description: Description,
 ThumbnailUrl: ThumbnailUrl,
 Credits: Credits,
 MediaType: 'labest',
 MediaNameTranslated: 'Lab Test' ,
 UniqueId: UniqueId
 }),
 linkText: Title,
 showTooltip: false,
 listName: 'LabTestResources' + $parent.key
 } } -->
 <!-- /ko -->
</script>
<script type="text/html" id="mediawidget-labtest-list-template">
 <!-- ko component: {name: 'multimedia-link-text', params: { item: ko.mapping.fromJS({
 ItemId: ItemId,
 IframeSrc: MediaUrl,
 Title: Title,
 ShareUrlTitle: ShareUrlTitle,
 Description: Description,
 ThumbnailUrl: ThumbnailUrl,
 Credits: Credits,
 MediaType: 'labtest',
 MediaNameTranslated: 'Lab Test',
 UniqueId: UniqueId
 }),
 linkText: Title,
 showTooltip: false,
 listName: 'LabTestResources' + $parent.key
 } } -->
 <!-- /ko -->
</script>
<script type="text/html" id="inlinemedia-featuredlink-template">
 <!-- ko ifnot: isText-->
 <!-- ko ifnot: isModal -->
 <a data-bind="attr: {href: IframeSrcComputed, target: Target}">
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <!-- ko if: isSideline() && !IsInCarousel() -->
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 <!-- /ko -->
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isSideline -->
 <figure class="box__figure">
 <img oncontextmenu="return false;" loading="lazy" class="box__picture" data-bind="attr: {src: ThumbnailUrl, alt: Title}" />
 <div class="box__action"></div>
 <div class="box__label" data-bind="text:MediaNameTranslated"></div>
 </figure>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }"></iframe>
 <!-- /ko -->
 </div>
 </div>
 </div>
 </a>
 <!-- /ko -->
 <!-- /ko -->
 <!-- ko if: isModal -->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <!-- ko if: isSideline() && !IsInCarousel() -->
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 <!-- /ko -->
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isSideline -->
 <figure class="box__figure">
 <img oncontextmenu="return false;" loading="lazy" class="box__picture" data-bind="attr: {src: ThumbnailUrl, alt: Title}" />
 <div class="box__action"></div>
 <div class="box__label" data-bind="text:MediaNameTranslated"></div>
 </figure>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }"></iframe>
 <!-- /ko -->
 </div>
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }">
 </div>
 <!-- /ko -->
</script><script type="text/html" id="featuredlink-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="yes" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, iOSresizeIframeToParent : attachResizeCallback" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description" data-bind="getDivRef : $parent.descriptionDivRef">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="iframe-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="auto" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="multimedia-thumbnail-template">
 <div class="modalcarousel__item" data-bind="event:{click: $parentContext.$parent.navToClick.bind($index()), keypress: $parentContext.$parent.navToClickKeyPress.bind($index())}, css: {'modalcarousel__item--active' : $parentContext.$parent.activeIndex() == $index()}, attr: { title: item.Title}, modalCarousel, css-static: 'modalcarousel__item--' + item.MediaType()" tabindex="0" role="button">
 <div class="modalcarousel__item--wrapper">
 <div class="modalcarousel__item--imagewrapper h-nocopy">
 <img oncontextmenu="return false;" data-bind="lazyload: {src: item.ThumbnailUrl, options: {loadOnlyInViewport: true} , updateTick: $parentContext.$parent.carouselScrollTick}, attr: {alt: item.Title }, scrollIntoView:$parentContext.$parent.activeIndex() == $index()" />
 </div>
 <div class="modalcarousel__item--text" data-bind="html: item.Title"> </div>
 </div>
 <div class="modalcarousel__item--number" data-bind="text: ($index() + 1)"></div>
 </div>
</script>
<script type="text/html" id="text-player-template">
 <div class="multimedia">
 <div class="multimedia__text" data-bind="html: Text"> </div>
 </div>
</script>
<script type="text/html" id="multimedia-link-block-template">
 <i class="inlinemedia__icon--open"
 data-bind="hoverVisible: enableHover, hoverTargetId: '.multimedia__link'"></i>
 <button class="multimedia__link--block" aria-expanded="false" data-bind="shortClick: showPlayer, attr : {'aria-label':'Expand the'+' '+ item.MediaNameTranslated()}"></button>
</script>
<script type="text/html" id="multimedia-link-text-template">
 <a class="multimedia__link--text" role="button" tabindex="0" aria-expanded="false" data-bind="shortClick: showPlayer, html: linkText, css: cssClass"></a>
</script><div class="multimedia__popup l-viewport" data-bind="component: { name: 'multimedia-popup'}">
 <!-- Placeholder for media players. -->
</div>
<script type="text/html" id="multimedia-popup-template">
 <!-- ko if: playerVisible -->
 <div class="modal" role="dialog" tabindex="-1" aria-labelledby="exampleModalLabel">
 <div class="modal--shade" data-bind="click: hidePopup"></div>
 <div class="modaldialog" data-bind=" arrowKeys: {left: showPrev, right: showNext}, css : {'h-expanded' : expanded }">
 <div class="modaldialog__header hide-on-print">
 <div class="modaldialog__header--wrapper">
 <div class="modaldialog__header--title modaldialog__header--element" data-bind="html: popupTitle(), scaleText: popupTitle"></div>
 <div tabindex="0" role="button" class="modaldialog__header--close modaldialog__header--element" data-bind="event: { click: hidePopup, keypress: hidePopupKeyPress }">
 Close
 </div>
 </div>
 </div>
 <div class="modaldialog__content">
 <div class="modaldialog__content--wrapper" data-bind="swipe: {next: showNext, prev: showPrev, canSwipe: canSwipe}">
 <div class="modaldialog__media" data-bind="css :{ 'modaldialog__media--withcarousel': !(displaySingle() || hideCarousel()), 'modaldialog__media--single': displaySingle }">
 <!-- ko ifnot: (displaySingle() || hideMainArrows()) -->
 <div class="modaldialog__media--sidemargin hide-on-print">
 <div class="modaldialog__media--nav modaldialog__media--prev" tabindex="0" role="button" aria-label="Previous" data-bind="event: { click: showPrev, keypress: showPrevKeyPress }">
 <div class="mm-icon" data-bind="css : showPrevClass()"></div>
 </div>
 </div>
 <!-- /ko -->
 <div class="modaldialog__media--wrapper">
 
 <!-- ko component: {name: activeEntry().item.MediaType() + '-player', params: activeEntry} -->
 <!-- /ko -->
 
 </div>
 <!-- ko ifnot: (displaySingle() || hideMainArrows()) -->
 <div class="modaldialog__media--sidemargin hide-on-print">
 <div class="modaldialog__media--nav modaldialog__media--next" tabindex="0" role="button" aria-label="Next" data-bind="event: { click: showNext, keypress: showNextKeyPress }">
 <div class="mm-icon" data-bind="css: showNextClass()"></div>
 </div>
 </div>
 <!-- /ko -->
 </div>
 <!-- ko ifnot: (displaySingle() || hideCarousel()) -->
 <div class="modaldialog__carousel hide-on-print">
 <div class="modaldialog__carousel--sidemargin modaldialog__carousel--prev" tabindex="0" role="button" data-bind="event:{click: carouselShowPrev, keypress:carouselShowPrevKeyPress}, css : { 'modaldialog__carousel--sidemargin--disabled' : isCarouselShowPrevDisabled() } "></div>
 <div class="modaldialog__carousel--wrapper">
 <div class="modalcarousel" data-bind="scrollTick : carouselScrollTick, scroll : carouselIsScrolled ">
 <!-- ko foreach: {data: activeList, as: 'entry'} -->
 <!-- ko template: {name: 'multimedia-thumbnail-template', data: entry} -->
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
 <div class="modaldialog__carousel--sidemargin modaldialog__carousel--next" tabindex="0" role="button" data-bind="event:{click: carouselShowNext, keypress:carouselShowNextKeyPress}, css : { 'modaldialog__carousel--sidemargin--disabled' : isCarouselShowNextDisabled() }"></div>
 </div>
 <!-- /ko -->
 <div class="modaldialog__toolbar hide-on-print">
 <!-- ko ifnot: displaySingle -->
 <div class="modaldialog__pager">
 <a class="modaldialog__pager--nav modaldialog__pager--navfirst" data-bind="click: showFirst">«</a>
 <a class="modaldialog__pager--nav modaldialog__pager--navleft" data-bind="click: showPrev">‹</a>
 <span class="modaldialog__pager--number" data-bind="text: activeEntry().index + 1"></span>/<span class="modaldialog__pager--number" data-bind="text: activeList().length"></span>
 <a class="modaldialog__pager--nav modaldialog__pager--navright" data-bind="click: showNext">›</a>
 <a class="modaldialog__pager--nav modaldialog__pager--navlast" data-bind="click: showLast">»</a>
 </div>
 <!-- /ko -->
 <div class="modaldialog__actions">
 <!-- ko if: detailsAvailable -->
 <div class="modaldialog__action modaldialog__action--description modaldialog__action--description-show" data-bind="click: toggleExpanded">
 <i class="modaldialog__icon--show"></i>
 <span class="modaldialog__action--text">
 Show Details
 </span>
 </div>
 <div class="modaldialog__action modaldialog__action--description modaldialog__action--description-hide" data-bind="click: toggleExpanded">
 <i class="modaldialog__icon--hide"></i>
 <span class="modaldialog__action--text">
 Hide Details
 </span>
 </div>
 <!-- /ko -->
 <!-- ko if: MManual.settings.socialMedia.enableMultimediaPopupShareButton -->
 <div class="modaldialog__action modaldialog__action--share a2a_kit" data-a2a-icon-color="transparent,transparent" data-bind="attr:{'data-a2a-url': shareUrl}">
 <a class="modaldialog__icon--share a2a_dd" href="https://www.addtoany.com/share" data-a2a-icon-color="transparent,transparent" role="button"></a>
 </div>
 <!-- /ko -->
 <div class="modaldialog__action modaldialog__action--print" data-bind="event:{click: printPopupContent, keypress:printPopupContentKeyPress}" tabindex="0" role="button" aria-label="print">
 <div class="modaldialog__icon--print"></div>
 </div>
 </div>
 </div>
 <div class="modaldialog__copyright-print">
 <div class="modaldialog__copyright-print--logo">
<img src="/Content/Images/msd_foot_logo.png" alt="" class="badge msd" loading="lazy" width="240" height="71" />
 </div>
 <div class="modaldialog__copyright-print--text">
 © 2024 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
</script>
<script type="text/html" id="podcast-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__audio hide-on-print">
 <div class="multimedia__audio--wrapper">
 <audio>
 <source data-bind="attr: { src: AudioUrl, type: MimeType }" />
 </audio>
 </div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content">
 <p data-bind="html: Description"></p>
 </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits">
 <p data-bind="html: Credits"></p>
 </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
 <script type="text/html" id="quiz-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <h3 class="multimedia__title" data-bind="html: Title"> </h3>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper h-ios-iframe-scroll">
 <iframe frameBorder="0" scrolling="auto" data-bind="attr: { src: IframeSrcComputed, title: Title }" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation, swipe: {left: parentContext.showNext, right: parentContext.showPrev}"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 </div>
</script>
<script type="text/html" id="table-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__table">
 <div class="multimedia__table--wrapper">
 <div data-bind="html: tableBody, stickyHeaderTable: tableBody" class="modaltable"> </div>
 </div>
 </div>
 <div class="multimedia__description">
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="m-link-text-template">
 <!-- ko if: isModal -->
 <a class="multimedia__link--text" tabindex="0" role="button" data-bind="shortClick: showPlayer, html: linkText, css: cssClass, attr: { title: item.Title }, mlinkToolTip: { thumbnail: item.ThumbnailUrl, title: item.Title, show: showTooltip, target: target }"></a>
 <!-- /ko -->
 <!-- ko ifnot: isModal -->
 <!--ko if: item.MediaType()=='podcast'-->
 <a class="multimedia__link--text" tabindex="0" role="button" data-bind="html: linkText, css: cssClass, attr: { title: item.Title, target: target, href: target=='_blank'? url :'https://www.msdmanuals.com/'+ url }, mlinkToolTip: { thumbnail: item.ThumbnailUrl, title: item.Title, show: showTooltip, target: target, url:url}"></a>
 <!-- /ko -->
 <!--ko ifnot: item.MediaType()=='podcast'-->
 <a class="multimedia__link--text" tabindex="0" role="button" data-bind="html: linkText, css: cssClass, attr: { title: item.Title, target: target, href: 'https://www.msdmanuals.com/'+'/professional/multimedia'+ url }, mlinkToolTip: { thumbnail: item.ThumbnailUrl, title: item.Title, show: showTooltip, target: target, url:'/professional/multimedia'+ url}"></a>
 <!-- /ko -->
 <!-- /ko -->
</script>
<script type="text/html" id="clinicalcalculator-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper h-ios-iframe-scroll">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="auto" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, setIframePrintTarget: setIframePrintTarget" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="inlinemedia-calculator-template">
 <!-- ko if: isSideline -->
 <div class="inlinebox inlinebox--clickable" data-bind="css: {'inlinebox--right': !IsInCarousel(), 'inlinebox--full': IsInCarousel}">
 <div class="inlinebox__wrapper">
 <!-- ko ifnot: IsInCarousel-->
 <div class="inlinebox__header">Clinical Calculator:</div>
 <!-- /ko -->
 <div class="inlinebox__content">
 <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: multimediaLinkModel }"></div>
 <div class="inlinebox__button">
 <img class="labtest-icon" loading="lazy" alt="icon" data-bind="attr: {src: ThumbnailUrl }" width="48" height="48" />
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 </div>
 <div class="inlinemedia__content">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrc, title: Title }"></iframe>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
<script type="text/html" id="video-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__video">
 <div class="multimedia__video--spacer"></div>
 <div class="multimedia__video--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }"></iframe>
 <div class="multimedia__video--print" onclick="$(this).hide(); return true;">
 <img loading="lazy" data-bind="attr: { src: ThumbnailUrl, alt: Title }">
 </div>
 </div>
 <div class="multimedia__video--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">Â«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">â€¹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">â€º</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">Â»</a>
 </div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content" data-bind="html: Description"> </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits" data-bind="html: Credits"> </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<link rel="stylesheet" href="./Content/Styles/fa/fonts/font-awesome.css" type="text/css" media="screen"><link rel="stylesheet" href="./CustomCss/custom_mobile_styles.css"><script type="text/javascript" src="./customscript/videodetail.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script><script type="text/javascript" src="./customscript/VideoPath.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script><script type="text/javascript" src="./customscript/Appdetail.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script><script type="text/javascript" src="./customscript/customscript.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script></head>
<body class="professional msd ">
 <a href="/n3wbr@nds" rel="nofollow" style="display:none" arial-hidden="true">honeypot link</a>
 <!-- Google Tag Manager (noscript) --> <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-5MKXR9" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript> <!-- End Google Tag Manager (noscript) --> 
 <div id="testone"> <div class="l-viewport">
 
<input type="hidden" id="currentSitecoreItemId" value="99f36709-190d-404e-bf6d-a0b1f6a706f0">
<input type="hidden" id="wasThisTopicHelpfulUrl" value="/Custom/Topic/WasThisTopicHelpful">
<input type="hidden" id="getTopicHelpfulUrl" value="/Custom/Topic/GetTopicHelpful">
<input type="hidden" id="languageSwitchUrl" value="/professional/LanguageSwitch">
<input type="hidden" id="resourceServiceUrl" value="/custom/Topic/GetTopicsForResource">
<input type="hidden" id="tableBodyServiceUrl" value="/custom/Topic/GetTableBody">
<input type="hidden" id="getAlphabetUrl" value="/Redesign/Widgets/GetAlphabet">
<input type="hidden" id="landingPageUrl" value="https://www.msdmanuals.com/">
<input type="hidden" id="standaloneMultimediaBaseUrl" value="/professional/multimedia">
<input type="hidden" id="currentEdition" value="Professional">
<input type="hidden" id="currentLanguage" value="en">
<input type="hidden" id="currentLanguage2LetterISO" value="en">
<input type="hidden" id="oldRestrictedBrightcovePlayer" value="3851244774001">
<input type="hidden" id="restrictedBrightcovePlayer" value="5qrY5f1MK_default">
<input type="hidden" id="shareableBrightcovePlayer" value="6CaKiGXJD_default">
<input type="hidden" id="selectLanguageLabel" value="Select Language">
<input type="hidden" id="commonCloseText" value="close">
<input type="hidden" id="readAllText" value="Read All">
 
 <!-- New div groups for LetterSpine and Header has been created
 due to problems with existing styling
 ToDo rewrite whole header and letter spine as one component -->
 <div id="l-group--header-letterpine" class="main-header sticky-header">
 <div class="l-group l-group--header">
 <div id="l-layer--header" class="l-layer l-layer--header" data-header-element-position="static" data-header-element-order="0">
 
 
 
 </div>
 </div>
 </div>
 
 
<script>
 MManual.Feature = MManual.Feature || {};
 MManual.Feature.LetterSpine = MManual.Feature.LetterSpine || {};
 MManual.Feature.LetterSpine.Id = '2e0e652b-fba3-4f1c-8563-b28937df9093';
</script>
 <!-- <div id="l-group--header-letterpine--fixed" class="main-header l-group--header-letterpine-fixed l-group--header-letterpine-fixed--hidden l-group--header-letterpine-fixed--animate">
 <div class="l-group l-group--headerfixed hide-on-print">
 <div class="l-layer l-layer--header l-layer--fixed" data-header-element-position="fixed" data-header-element-order="0">
 
 
 </div>
 </div>
 <div class="l-group l-group--letterspinefixed"></div>
 </div>
 <div class="l-layer l-layer--underskirt">
 </div>-->
 
 
 
 <div class="l-layer l-layer--actiontoolbar">
 
 <div class="l-layer__content">
 <aside class="actiontoolbar hide-on-print">
 <!--<a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--bookmark" onclick="bookmarkPage(this);" href="#"></a>-->
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--download" style="display: none" href="#"></a>
 
 <ul>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--share a2a_dd" href="https://www.addtoany.com/share" rel="noopener" role="button" aria-expanded="false" aria-label="Share in"></a>
 </li>
 <li>
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--print" href="#" onclick="window.print(); MManual.analytics.notifyOpenModal(MManual.analytics.eventPrintAnArticle);" role="button" title="print"></a>
 </li>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--email a2a_button_email" href="#" role="button" title="Mail"></a>
 </li>
 <li class="scroll-to-top">
 <a href="#top" role="button" aria-label="Go To Top" title="Go To Top"><span class="scroll-to-top-img"></span></a>
 </li>
 <li class="scroll-to-bottom">
 <a href="#" role="button" aria-label="Go To Top"><span class="scroll-to-bottom-img"></span></a>
 </li>
 </ul>
 </aside>
 </div>
 
 </div>
 <main id="maincontent" class="l-layer l-layer--main">
 
 <section class="l-layer__content main">
 
 <div class="orderize"></div>
<div class="main__content">
 <div class="topic__wrapper">
 
<script type="text/javascript">
 var resources = [];
 var resourcesIdList = [];
 $.each(resources, function() {
 if (this.MultimediaItem != null) {
 resourcesIdList.push({"itemId": this.MultimediaItem.ItemId, "uniqueId": this.MultimediaItem.UniqueId});
 }
 });
 $('a[href="#also-of-interest-news"],a[href="#also-of-interest-video"],a[href="#also-of-interest-biodigital"],a[href="#also-of-interest-student-stories"]').click(function ()
 {
 window.scrollTo(0, $("#Ph-Item-Lazyloading").offset().top - 230);
 });
</script>
<div class="orderize__candidate" data-orderize="100" itemscope="" itemtype="http://schema.org/MedicalCondition" data-preview-container='.topic__article'>
 <input type="hidden" value="" id="hdnTopicTopTile">
 <div class="autoload-placeholder-top hide-on-print" style="display:none">
 <a class="pre-topic hide-on-print" role="button" aria-hidden="true"></a>
 </div>
 <div class="autoloadSettings" name="Up Next:">
 <a id="autoloadEnable" class="false" role="button" tabindex="-1"></a>
 <a id="autoloadChapter" class="false" role="button" tabindex="-1"></a>
 <a id="autoloadSection" class="false" role="button" tabindex="-1"></a>
 <a id="stopAutoloadChapterCircular" class="false" role="button" tabindex="-1"></a>
 </div>
 <article class="topic__article">
 
<div class="tablebox tablebox--headings">
 <div class="tablebox__cell tablebox__cell--headings">
 <div class="topic__headings">
 <span itemprop="code" itemscope="" itemtype="http://schema.org/MedicalCode">

 </span>
 <div class="topic__header--container">
 <div class="topic__authors topic__authors--container">
 <a id="top" role="button" tabindex="-1"></a>
 <h1 class="topic__header__headermodify--title topic__header__headermodify--title--animate" itemprop="name">
 Medications for Deep Venous Thrombosis
 </h1>
 <div class="topic__authors-main-cont">
 <p class="topic__authors--description">By </p>
 
 <strong class="topic__label topic__label--author"><a href="./Contributors/douketis-james.html">James D. Douketis</a></strong>
 <p class="topic__authors--description">, MD, McMaster University</p>
 <div class="topic__revision">
 <div class="topic__authors">
 Reviewed/Revised Dec 2023 
 </div>
 </div>
 </div>
 </div>
 <div class="topic__buttons hide-on-print">
 <div class="topicswitch topic__patient-education topic__patient-education--top" data-icd9="MM1240" tabindex="0" role="link">
 <div class="topic__patient-education--container">
 <div class="topic__patient-education--icon"></div>
 <div class="topic__patient-education--text">
 View PATIENT EDUCATION
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
</div>
 <div class="box topicmenu hide-on-print">
 <div class="topic-section-heading-list">
 <ul>
 <li>
 <a href="#v45392037" class="topicmenu_mobile__paragraph">Anticoagulants</a>
 </li>
 <li>
 <a href="#v45392212" class="topicmenu_mobile__paragraph">Bleeding During Use of Anticoagulants</a>
 </li>
 <li>
 <a href="#v45392286" class="topicmenu_mobile__paragraph">Thrombolytic (Fibrinolytic) Agents</a>
 </li>
 <li>
 <a href="#v87251714" class="topicmenu_mobile__paragraph">More Information</a>
 </li>
 </ul>
 </div>
 </div>
<div class="topic__resources--title hide-on-print">
 Topic Resources
</div>
<div id="topicResources" class="hero hide-on-print">
 <div class="hero__tabs">
 <ul class="hero__header">
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Biodigitals'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 3D Models (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Biodigitals" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Biodigitals'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Audios'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 Audios (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Audios" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Audios'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Calculators'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 Calculators (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Calculators" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Calculators'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell " data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Images'}">
 <a data-bind="event: { click: function() { $data.activateGroup('Images'); }, keypress: function() { $data.activateGroup('Images'); }}" class="hero__link" tabindex="0" role="tab" aria-expanded="false" false="">
 <span class="hero__title">
 Images (1)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Images" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Images'}">
 <div class="floatbox">
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--image" data-group-name="image" title="Anticoagulants and Their Sites of Action">
 <div class="hero__image--image">
 <div class="hero__container">
 <img class="hero__image--image" src="./~/media/manual/professional/images/h/e/m/hem_pathways_coagulation_drugs.gif?mw=350&amp;thn=0&amp;sc_lang=en" width="600" height="393" loading="lazy">
 </div>
 <span class="hero__description">
 Anticoagulants and Their...
 </span>
 </div>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"Alt":"Anticoagulants and Their Sites of Action","Credits":"","IsRestricted":true,"ItemId":"52f0f8d7-ab7f-46c4-ab0a-650d4062a0da","Title":"Anticoagulants%20and%20Their%20Sites%20of%20Action","ShareUrlTitle":"anticoagulants-and-their-sites-of-action","Description":"%3Cp%3ELMWH%20%3D%20low%20molecular%20weight%20heparin%3B%20TF%20%3D%20tissue%20factor%3B%20UFH%20%3D%20unfractionated%20heparin.%3C%2Fp%3E","ImageUrl":"./~/media/manual/professional/images/h/e/m/hem_pathways_coagulation_drugs.gif?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/h/e/m/hem_pathways_coagulation_drugs.gif?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"HEM_pathways_coagulation_drugs.ai","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":"600","ImageHeight":"393","IframeSrc":null,"Target":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Anticoagulants%20and%20Their%20Sites%20of%20Action","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Image","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell " data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Tables'}">
 <a data-bind="event: { click: function() { $data.activateGroup('Tables'); }, keypress: function() { $data.activateGroup('Tables'); }}" class="hero__link" tabindex="0" role="tab" aria-expanded="false" false="">
 <span class="hero__title">
 Tables (1)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Tables" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Tables'}">
 <div class="floatbox">
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--table" data-group-name="table" title="Direct Oral Anticoagulants for Treatment of Venous Thromboembolism">
 <div class="hero__table">
 <img class="hero__table--image" src="./Content/Images/Redesign/table/icon_table_red.png" loading="lazy">
 </div>
 <span class="hero__description">
 Direct Oral Anticoagulants...
 </span>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"ItemId":"003a07f4-b7ee-47e3-8c8a-6afc1968d72e","Title":"Direct%20Oral%20Anticoagulants%20for%20Treatment%20of%20Venous%20Thromboembolism","ShareUrlTitle":"direct-oral-anticoagulants-for-treatment-of-venous-thromboembolism","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v45392065","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Direct%20Oral%20Anticoagulants%20for%20Treatment%20of%20Venous%20Thromboembolism","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Videos'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 Videos (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Videos" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Videos'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 </ul>
 </div>
</div>
<div class="topic__accordion">
 <span id="v45392027" class="anchor"></span><div class="para"> <p>Almost all patients with deep venous thrombosis (DVT) are given <a href="./{40A030FA-C405-40DB-867D-6853F28279BE}.html#v941167" data-toggle="tooltip" title="Anticoagulants" data-id="e78f09a3-b666-46de-876c-b43560680523" data-itemid="40a030fa-c405-40db-867d-6853f28279be">anticoagulants</a><span id="e78f09a3-b666-46de-876c-b43560680523" class="d-none xref"> <span class="tooltip-container"> <a href="./{40A030FA-C405-40DB-867D-6853F28279BE}.html#v941167"> <span class="tooltip-content"> <span class="tooltip-heading"> Anticoagulants </span> Deep venous thrombosis (DVT) is clotting of blood in a deep vein of an extremity (usually calf or thigh) or the pelvis. DVT is the primary cause of pulmonary embolism. DVT results from conditions... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/4/3/a/43a-and-43b-doppler-ultrasound-patient-with-a-thrombus-in-femoral-vein-ctisus.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Anticoagulants" loading="lazy"> </span> </a> </span> </span> and in rare cases <a href="./{40A030FA-C405-40DB-867D-6853F28279BE}.html#v941212" data-toggle="tooltip" title="Thrombolytic (fibrinolytic) therapy" data-id="34576b20-decc-4c51-8f71-27b4d3a4a415" data-itemid="40a030fa-c405-40db-867d-6853f28279be">thrombolytics</a><span id="34576b20-decc-4c51-8f71-27b4d3a4a415" class="d-none xref"> <span class="tooltip-container"> <a href="./{40A030FA-C405-40DB-867D-6853F28279BE}.html#v941212"> <span class="tooltip-content"> <span class="tooltip-heading"> Thrombolytic (fibrinolytic) therapy </span> Deep venous thrombosis (DVT) is clotting of blood in a deep vein of an extremity (usually calf or thigh) or the pelvis. DVT is the primary cause of pulmonary embolism. DVT results from conditions... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/4/3/a/43a-and-43b-doppler-ultrasound-patient-with-a-thrombus-in-femoral-vein-ctisus.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Thrombolytic (fibrinolytic) therapy" loading="lazy"> </span> </a> </span> </span>. A number of anticoagulants are effective for management of deep venous thrombosis (see also <a href="./{40A030FA-C405-40DB-867D-6853F28279BE}.html" data-toggle="tooltip" title="Deep Venous Thrombosis (DVT)" data-id="2b3599b3-acc7-4422-ace6-f6fc7fac67f0" data-itemid="40a030fa-c405-40db-867d-6853f28279be">Deep Venous Thrombosis</a><span id="2b3599b3-acc7-4422-ace6-f6fc7fac67f0" class="d-none xref"> <span class="tooltip-container"> <a href="./{40A030FA-C405-40DB-867D-6853F28279BE}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Deep Venous Thrombosis (DVT) </span> Deep venous thrombosis (DVT) is clotting of blood in a deep vein of an extremity (usually calf or thigh) or the pelvis. DVT is the primary cause of pulmonary embolism. DVT results from conditions... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/4/3/a/43a-and-43b-doppler-ultrasound-patient-with-a-thrombus-in-femoral-vein-ctisus.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Deep Venous Thrombosis (DVT)" loading="lazy"> </span> </a> </span> </span>). </p></div><span id="v45392031" class="anchor"></span><div class="para"> <p>Non-pharmacologic treatments include <a href="./{40A030FA-C405-40DB-867D-6853F28279BE}.html#v941216" data-toggle="tooltip" title="Surgery" data-id="284df7ec-c9ad-4159-9731-af89d46bcb93" data-itemid="40a030fa-c405-40db-867d-6853f28279be">surgery</a><span id="284df7ec-c9ad-4159-9731-af89d46bcb93" class="d-none xref"> <span class="tooltip-container"> <a href="./{40A030FA-C405-40DB-867D-6853F28279BE}.html#v941216"> <span class="tooltip-content"> <span class="tooltip-heading"> Surgery </span> Deep venous thrombosis (DVT) is clotting of blood in a deep vein of an extremity (usually calf or thigh) or the pelvis. DVT is the primary cause of pulmonary embolism. DVT results from conditions... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/4/3/a/43a-and-43b-doppler-ultrasound-patient-with-a-thrombus-in-femoral-vein-ctisus.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Surgery" loading="lazy"> </span> </a> </span> </span> and <a href="./{40A030FA-C405-40DB-867D-6853F28279BE}.html#v941206" data-toggle="tooltip" title="Inferior vena cava (IVC) filter" data-id="9441881e-1944-462c-9253-eaec6bb09fee" data-itemid="40a030fa-c405-40db-867d-6853f28279be">inferior vena cava filters</a><span id="9441881e-1944-462c-9253-eaec6bb09fee" class="d-none xref"> <span class="tooltip-container"> <a href="./{40A030FA-C405-40DB-867D-6853F28279BE}.html#v941206"> <span class="tooltip-content"> <span class="tooltip-heading"> Inferior vena cava (IVC) filter </span> Deep venous thrombosis (DVT) is clotting of blood in a deep vein of an extremity (usually calf or thigh) or the pelvis. DVT is the primary cause of pulmonary embolism. DVT results from conditions... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/4/3/a/43a-and-43b-doppler-ultrasound-patient-with-a-thrombus-in-femoral-vein-ctisus.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Inferior vena cava (IVC) filter " loading="lazy"> </span> </a> </span> </span>. </p></div> <section id="v45392037" class="topic__section FHead"> <h2 id="" class="topic__header--section"> <span id="v45392038" class="anchor"></span> Anticoagulants </h2> <div class="topic__content"> <span id="v45392039" class="anchor"></span><div class="para"> <p>The anticoagulants (see figure <span class="multimedia__link mlinkBlock" data-bind="component: { name: 'm-link-text', params: $data }" data-popup-model='{"ItemId":"d4948c28-bffc-4204-a968-9c30810f044e","Title":"Anticoagulants%20and%20Their%20Sites%20of%20Action","ShareUrlTitle":"anticoagulants-and-their-sites-of-action","Description":"","ImageUrl":null,"ThumbnailUrl":"/-/media/manual/professional/images/h/e/m/hem_pathways_coagulation_drugs.gif?sc_lang=en","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v59177550","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicMultimedia","LinkText":"%3Cspan%20%3EAnticoagulants%20and%20Their%20Sites%20of%20Action%3C%2Fspan%3E","CssClass":null,"LoadLocations":true,"ShowTooltip":true,"SingleItem":true,"ExcludeFromBrand":"","ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":"modal","Url":null,"HideMainArrows":false}'></span> and table <span class="multimedia__link mlinkBlock" data-bind="component: { name: 'm-link-text', params: $data }" data-popup-model='{"ItemId":"b71ae740-c406-45d3-b8e5-e105cd9df3ff","Title":"Oral%20Anticoagulants","ShareUrlTitle":"oral-anticoagulants","Description":"","ImageUrl":null,"ThumbnailUrl":"/Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v55610275","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicMultimedia","LinkText":"%3Cspan%20%3EOral%20Anticoagulants%3C%2Fspan%3E","CssClass":null,"LoadLocations":true,"ShowTooltip":true,"SingleItem":true,"ExcludeFromBrand":"","ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":"modal","Url":null,"HideMainArrows":false}'></span>) include</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v45392044" class="anchor"></span><div class="para"> <p>Low molecular weight heparins (LMWHs)</p></div></li><li class="topic__listitem"><span id="v45392046" class="anchor"></span><div class="para"> <p>Unfractionated <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span> (UFH)</p></div></li><li class="topic__listitem"><span id="v45392048" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Factor Xa</span> inhibitors: oral (eg, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>rivaroxaban</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>apixaban</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>edoxaban</span>) and parenteral (<span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>fondaparinux</span>)</p></div></li><li class="topic__listitem"><span id="v45392050" class="anchor"></span><div class="para"> <p>Direct <span class="genericDrug" data-showrollover="false">thrombin</span> inhibitors: oral (<span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>dabigatran</span> etexilate) and parenteral (<span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>argatroban</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>bivalirudin</span>, desirudin)</p></div></li><li class="topic__listitem"><span id="v45392052" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Warfarin</span></p></div></li></ul></div><span id="v45392053" class="anchor"></span><div class="para"> <p>Oral <span class="genericDrug" data-showrollover="false">factor Xa</span> inhibitors and direct <span class="genericDrug" data-showrollover="false">thrombin</span> inhibitors are sometimes referred to as direct oral anticoagulants (DOACs). However, there are also parenteral agents that inhibit both <span class="genericDrug" data-showrollover="false">factor Xa</span> and <span class="genericDrug" data-showrollover="false">thrombin</span> (unfractionated <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span>), that inhibit mainly <span class="genericDrug" data-showrollover="false">factor Xa</span> (LMWH), or that inhibit only <span class="genericDrug" data-showrollover="false">factor Xa</span> (<span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>fondaparinux</span>). These agents can be used both for patients with DVT and those with pulmonary embolism (PE). </p></div> <span id="v45392054"></span> <div data-mmanualobjecttype="illustrativeMaterial" class="inlinebox--right inlinebox--figure "> <div class="inlinebox__wrapper"> <div class="inlinebox__content"> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v45392056"></span> <div class="FigureHalfPage" id="v45392055"> <h3 class="title">Anticoagulants and Their Sites of Action</h3> <div class="tableWrapper"> <table> <tbody><tr class="odd"><td><span id="v45392062" class="anchor"></span><div class="para"> <p>LMWH = low molecular weight <span class="genericDrug" data-showrollover="false">heparin</span>; TF = tissue factor; UFH = unfractionated <span class="genericDrug" data-showrollover="false">heparin</span>.</p></div> <div class="inlinemedia__container"> <div class="inlinemedia__image--container"> <img oncontextmenu="return false;" data-mmanualobjecttype="Image" src="./~/media/manual/professional/images/h/e/m/hem_pathways_coagulation_drugs.gif?thn=0&sc_lang=en" alt="Anticoagulants and Their Sites of Action" lang="" loading="lazy" height="393" width="600"> <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: $data }" data-popup-model='{"Alt":"Anticoagulants and Their Sites of Action","Credits":"","IsRestricted":true,"ItemId":"52f0f8d7-ab7f-46c4-ab0a-650d4062a0da","Title":"Anticoagulants%20and%20Their%20Sites%20of%20Action","ShareUrlTitle":"anticoagulants-and-their-sites-of-action","Description":"%3Cp%3ELMWH%20%3D%20low%20molecular%20weight%20heparin%3B%20TF%20%3D%20tissue%20factor%3B%20UFH%20%3D%20unfractionated%20heparin.%3C%2Fp%3E","ImageUrl":"./~/media/manual/professional/images/h/e/m/hem_pathways_coagulation_drugs.gif?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/h/e/m/hem_pathways_coagulation_drugs.gif?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"HEM_pathways_coagulation_drugs.ai","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":"600","ImageHeight":"393","IframeSrc":null,"Target":null}' data-popup-options='{"ListName":"","LinkText":"Anticoagulants%20and%20Their%20Sites%20of%20Action","CssClass":null,"LoadLocations":false,"ShowTooltip":false,"SingleItem":true,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Image","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":true,"ShowTitleInHeader":false,"HideCarousel":true,"Target":null,"Url":null,"HideMainArrows":false}'> </div> </div> </div></td></tr></tbody> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div> <div> </div> </div> </div> <!-- Type: Figure --> </div> <span id="v45392064"></span> <div data-mmanualobjecttype="illustrativeMaterial" class="inlinebox--full inlinebox--table inlinebox--clickable illustrativeMaterialTable "> <div class="inlinebox__wrapper" id="v45392066"> <div class="inlinebox__header">Table</div> <div class="inlinebox__content"> <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: $data }" data-popup-model='{"ItemId":"003a07f4-b7ee-47e3-8c8a-6afc1968d72e","Title":"Direct%20Oral%20Anticoagulants%20for%20Treatment%20of%20Venous%20Thromboembolism","ShareUrlTitle":"direct-oral-anticoagulants-for-treatment-of-venous-thromboembolism","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v45392065","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"","LinkText":"Direct%20Oral%20Anticoagulants%20for%20Treatment%20of%20Venous%20Thromboembolism","CssClass":null,"LoadLocations":false,"ShowTooltip":false,"SingleItem":true,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":true,"Target":null,"Url":null,"HideMainArrows":false}'> </div> <div class="inlinebox__button"> <img src="./Content/Images/Redesign/table/icon_table_red.png" alt="" loading="lazy" width="55" height="42"> </div> <div class="inlinebox__content--print" id="003a07f4-b7ee-47e3-8c8a-6afc1968d72e"> </div> </div> </div> <!-- Type: Table --> </div> <script type="text/javascript"> $(document).ready(function () { var url = window.location; if (url.search.includes("media=print")) { $.ajax({ url: '/Redesign/Topic/GetTableBody', type: "GET", dataType: "json", data: { tableId: '003a07f4-b7ee-47e3-8c8a-6afc1968d72e' }, async: true, success: function (data) { $('#003a07f4-b7ee-47e3-8c8a-6afc1968d72e').html('<div class="modaldialog">'+ data.TableBody + '</div>'); }, error: function (jqxhr, textStatus, errorThrown) { console.error(errorThrown); } }); } }); </script> <section id="v45392139" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v45392140" class="anchor"></span> Anticoagulation strategies for DVT </h3> <div class="topic__content"> <span id="v45392141" class="anchor"></span><div class="para"> <p>There are several strategies for anticoagulation of patients with DVT: </p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v45392144" class="anchor"></span><div class="para"> <p>Initial treatment with an injectable <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span> (unfractionated or low molecular weight) followed after several days by long-term treatment with an oral drug (<span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>warfarin</span>, a <span class="genericDrug" data-showrollover="false">factor Xa</span> inhibitor, or a direct <span class="genericDrug" data-showrollover="false">thrombin</span> inhibitor)</p></div></li><li class="topic__listitem"><span id="v45392146" class="anchor"></span><div class="para"> <p>Initial and long-term treatment with a LMWH</p></div></li><li class="topic__listitem"><span id="v45392148" class="anchor"></span><div class="para"> <p>Initial and long-term treatment with certain oral <span class="genericDrug" data-showrollover="false">factor Xa</span> inhibitors (<span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>rivaroxaban</span> or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>apixaban</span>)</p></div></li></ul></div><span id="v87251650" class="anchor"></span><div class="para"> <p>Dosing regimens for treatment of DVT differ from those used for prevention of thromboembolism in patients with <a href="./{3118C057-FB1F-4AA1-8B87-C346CBC408C3}.html" data-toggle="tooltip" title="Atrial Fibrillation" data-id="66bf2325-9c10-469b-b907-a91cf8f9c3ac" data-itemid="3118c057-fb1f-4aa1-8b87-c346cbc408c3">atrial fibrillation</a><span id="66bf2325-9c10-469b-b907-a91cf8f9c3ac" class="d-none xref"> <span class="tooltip-container"> <a href="./{3118C057-FB1F-4AA1-8B87-C346CBC408C3}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Atrial Fibrillation </span> Atrial fibrillation is a rapid, irregularly irregular atrial rhythm. Symptoms include palpitations and sometimes weakness, effort intolerance, dyspnea, and presyncope. Atrial thrombi may form... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>.</p></div><span id="v45392149" class="anchor"></span><div class="para"> <p>Some, but not all, of the direct oral anticoagulants are alternatives to <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>warfarin</span> as 1st-line treatment for DVT and PE and may also be used as monotherapy (see table <span class="multimedia__link mlinkBlock" data-bind="component: { name: 'm-link-text', params: $data }" data-popup-model='{"ItemId":"b71ae740-c406-45d3-b8e5-e105cd9df3ff","Title":"Oral%20Anticoagulants","ShareUrlTitle":"oral-anticoagulants","Description":"","ImageUrl":null,"ThumbnailUrl":"/Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v55610275","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicMultimedia","LinkText":"%3Cspan%20%3EOral%20Anticoagulants%3C%2Fspan%3E","CssClass":null,"LoadLocations":true,"ShowTooltip":true,"SingleItem":true,"ExcludeFromBrand":"","ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":"modal","Url":null,"HideMainArrows":false}'></span>). Compared to <span class="genericDrug" data-showrollover="false">warfarin</span>, these medications have been shown to give similar protection against recurrent DVT and have similar (or with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>apixaban</span>, perhaps lower) risk of serious bleeding (<a href="./{99F36709-190D-404E-BF6D-A0B1F6A706F0}.html#v45392199" data-toggle="tooltip" title="Anticoagulant treatment references" data-id="24859aa9-826b-4e80-9c6c-709070d25e13" data-itemid="99f36709-190d-404e-bf6d-a0b1f6a706f0">1</a><span id="24859aa9-826b-4e80-9c6c-709070d25e13" class="d-none xref"> <span class="tooltip-container"> <a href="./{99F36709-190D-404E-BF6D-A0B1F6A706F0}.html#v45392199"> <span class="tooltip-content"> <span class="tooltip-heading"> Anticoagulant treatment references </span> Almost all patients with deep venous thrombosis (DVT) are given anticoagulants and in rare cases thrombolytics. A number of anticoagulants are effective for management of deep venous thrombosis... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). </p></div><span id="v45392152" class="anchor"></span><div class="para"> <p>Their advantages are that they are effective within several hours and thus do not require a period of overlapping treatment with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span> (bridging treatment), although <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>edoxaban</span> and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>dabigatran</span> require at least 5 days of pretreatment with an injectable anticoagulant. Also, they are given as a fixed dose and thus, unlike <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>warfarin</span>, do not require ongoing laboratory testing. </p></div><span id="v45392153" class="anchor"></span><div class="para"> <p>The main disadvantage is the higher cost compared to <span class="genericDrug" data-showrollover="false">warfarin</span> and the high cost of DOAC reversal agents in the case of bleeding or need for an urgent surgery or procedure. </p></div><span id="v45392154" class="anchor"></span><div class="para"> <p><b>Duration of treatment</b> varies. Patients with transient risk factors for DVT (eg, immobilization, surgery) can usually stop taking anticoagulants after 3 to 6 months. Patients with idiopathic (or unprovoked) DVT with no known risk factors, or recurrent DVT should take anticoagulants for at least 6 months and, in selected patients, probably for life unless they are at high risk for bleeding complications. Patients with cancer-associated thrombosis should receive at least 3 months of anticoagulation. Treatment is usually longer in patients receiving ongoing cancer therapy and in patients with advanced, metastatic disease. Patients with selected hypercoagulable states (eg, <a href="./{44CEDC40-68D1-4D39-B8AF-97CC5C64D120}.html" data-toggle="tooltip" title="Antiphospholipid Syndrome (APS)" data-id="70f48e42-e8a2-47f7-bfe6-d5dfd61cbd83" data-itemid="44cedc40-68d1-4d39-b8af-97cc5c64d120">antiphospholipid syndrome</a><span id="70f48e42-e8a2-47f7-bfe6-d5dfd61cbd83" class="d-none xref"> <span class="tooltip-container"> <a href="./{44CEDC40-68D1-4D39-B8AF-97CC5C64D120}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Antiphospholipid Syndrome (APS) </span> Antiphospholipid syndrome is an autoimmune disorder characterized by venous and arterial thrombosis or pregnancy complications (eg, recurrent miscarriage) and persistent autoantibodies to phospholipid-bound... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> or <a href="./{9C575C78-50DE-4E82-A630-2B8FD6D5F283}.html" data-toggle="tooltip" title="Protein C Deficiency" data-id="69289352-38c2-40f6-96e7-f7776d9f9ad2" data-itemid="9c575c78-50de-4e82-a630-2b8fd6d5f283">protein C</a><span id="69289352-38c2-40f6-96e7-f7776d9f9ad2" class="d-none xref"> <span class="tooltip-container"> <a href="./{9C575C78-50DE-4E82-A630-2B8FD6D5F283}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Protein C Deficiency </span> Because activated protein C degrades coagulation factors Va and VIIIa, deficiency of protein C predisposes to venous thrombosis. (See also Overview of Thrombotic Disorders.) Protein C is a vitamin... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, <a href="./{BB2C9709-6481-457C-8632-F9ABAF438A8B}.html" data-toggle="tooltip" title="Protein S Deficiency" data-id="339e92f0-d638-4a30-985a-6e2423a09efc" data-itemid="bb2c9709-6481-457c-8632-f9abaf438a8b">protein S</a><span id="339e92f0-d638-4a30-985a-6e2423a09efc" class="d-none xref"> <span class="tooltip-container"> <a href="./{BB2C9709-6481-457C-8632-F9ABAF438A8B}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Protein S Deficiency </span> Because protein S binds and assists activated protein C in the degradation of coagulation factors Va and VIIIa, deficiency of protein S predisposes to venous thrombosis. (See also Overview of... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, or <a href="./{D55E1ACF-89CD-45CE-9A6C-75373F12186A}.html" data-toggle="tooltip" title="Antithrombin Deficiency" data-id="3fe43960-6426-4ca5-ab92-f3648b53522a" data-itemid="d55e1acf-89cd-45ce-9a6c-75373f12186a">antithrombin</a><span id="3fe43960-6426-4ca5-ab92-f3648b53522a" class="d-none xref"> <span class="tooltip-container"> <a href="./{D55E1ACF-89CD-45CE-9A6C-75373F12186A}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Antithrombin Deficiency </span> Because antithrombin inhibits thrombin and factors Xa, IXa, and XIa, deficiency of antithrombin predisposes to venous thrombosis. (See also Overview of Thrombotic Disorders.) Antithrombin is... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> deficiency) should also be considered for extended-duration anticoagulation. </p></div> </div> </section> <section id="v45392159" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v45392160" class="anchor"></span> Low molecular weight heparins (LMWHs) </h3> <div class="topic__content"> <span id="v45392161" class="anchor"></span><div class="para"> <p>A low molecular weight <span class="genericDrug" data-showrollover="false">heparin</span> (eg, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>enoxaparin</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>dalteparin</span>, tinzaparin) is one of the initial treatments of choice because LMWHs can be given on an outpatient basis. LMWHs are as effective as unfractionated <span class="genericDrug" data-showrollover="false">heparin</span> (UFH) for reducing DVT recurrence, thrombus extension, and risk of death due to PE (<a href="./{99F36709-190D-404E-BF6D-A0B1F6A706F0}.html#v45392199" data-toggle="tooltip" title="Anticoagulant treatment references" data-id="dd4484f9-2fa7-47c6-972c-bf9da6bbee70" data-itemid="99f36709-190d-404e-bf6d-a0b1f6a706f0">2</a><span id="dd4484f9-2fa7-47c6-972c-bf9da6bbee70" class="d-none xref"> <span class="tooltip-container"> <a href="./{99F36709-190D-404E-BF6D-A0B1F6A706F0}.html#v45392199"> <span class="tooltip-content"> <span class="tooltip-heading"> Anticoagulant treatment references </span> Almost all patients with deep venous thrombosis (DVT) are given anticoagulants and in rare cases thrombolytics. A number of anticoagulants are effective for management of deep venous thrombosis... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). Like UFH, LMWHs catalyze the action of antithrombin (which inhibits coagulation factor proteases), leading to inactivation of coagulation <span class="genericDrug" data-showrollover="false">factor Xa</span> and, to a lesser degree, factor IIa. LMWHs also have some antithrombin–mediated anti-inflammatory properties, which facilitate clot organization and resolution of symptoms and inflammation.</p></div><span id="v45392163" class="anchor"></span><div class="para"> <p>LMWHs are typically given subcutaneously in a standard weight-based dose (eg, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>enoxaparin</span> 1.5 mg/kg subcutaneously once a day or 1 mg/kg subcutaneously every 12 hours or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>dalteparin</span> 200 units/kg subcutaneously once a day). Patients with renal insufficiency may be treated with UFH or with reduced doses of LMWH. Monitoring is not reliable because LMWHs do not significantly prolong the results of global tests of coagulation. Furthermore, they have a predictable dose response, and there is no clear relationship between the anticoagulant effect of LMWH and bleeding. If <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>warfarin</span> is used after initial anticoagulation, treatment with LMWH is continued until full anticoagulation is achieved with <span class="genericDrug" data-showrollover="false">warfarin</span> (typically about 5 days). Transition to the oral agents <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>rivaroxaban</span> or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>apixaban</span> can be done at any time with no overlap. Transition to <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>edoxaban</span> or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>dabigatran</span> requires at least 5 days of LMWH treatment, but no overlap is needed.</p></div><span id="v45392164" class="anchor"></span><div class="para"> <p>LMWHs and direct oral anticoagulants are first-line treatment options for patients with cancer-associated DVT (<a href="./{99F36709-190D-404E-BF6D-A0B1F6A706F0}.html#v45392199" data-toggle="tooltip" title="Anticoagulant treatment references" data-id="c93c0122-3683-4b48-9229-a8bfa7b290e3" data-itemid="99f36709-190d-404e-bf6d-a0b1f6a706f0">3</a><span id="c93c0122-3683-4b48-9229-a8bfa7b290e3" class="d-none xref"> <span class="tooltip-container"> <a href="./{99F36709-190D-404E-BF6D-A0B1F6A706F0}.html#v45392199"> <span class="tooltip-content"> <span class="tooltip-heading"> Anticoagulant treatment references </span> Almost all patients with deep venous thrombosis (DVT) are given anticoagulants and in rare cases thrombolytics. A number of anticoagulants are effective for management of deep venous thrombosis... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>), including in patients who have a central venous catheter and develop DVT. <span class="genericDrug" data-showrollover="false">Warfarin</span> is a 2nd-line alternative due to its low cost, but use requires careful monitoring. </p></div><span id="v87251661" class="anchor"></span><div class="para"> <p>Complications of LMWHs include <a href="./{99F36709-190D-404E-BF6D-A0B1F6A706F0}.html#v45392213" data-toggle="tooltip" title="Bleeding During Use of Anticoagulants" data-id="0c530c14-3796-43f7-ba43-426e5722c047" data-itemid="99f36709-190d-404e-bf6d-a0b1f6a706f0">bleeding</a><span id="0c530c14-3796-43f7-ba43-426e5722c047" class="d-none xref"> <span class="tooltip-container"> <a href="./{99F36709-190D-404E-BF6D-A0B1F6A706F0}.html#v45392213"> <span class="tooltip-content"> <span class="tooltip-heading"> Bleeding During Use of Anticoagulants </span> Almost all patients with deep venous thrombosis (DVT) are given anticoagulants and in rare cases thrombolytics. A number of anticoagulants are effective for management of deep venous thrombosis... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, <a href="./{71EC671B-8559-4245-A3A6-B7AFF664C972}.html#v29269145" data-toggle="tooltip" title="Heparin-induced thrombocytopenia" data-id="20bf365e-bfa2-4360-a4d8-2fb72f4ebb7f" data-itemid="71ec671b-8559-4245-a3a6-b7aff664c972">thrombocytopenia</a><span id="20bf365e-bfa2-4360-a4d8-2fb72f4ebb7f" class="d-none xref"> <span class="tooltip-container"> <a href="./{71EC671B-8559-4245-A3A6-B7AFF664C972}.html#v29269145"> <span class="tooltip-content"> <span class="tooltip-heading"> Heparin-induced thrombocytopenia </span> Platelet destruction can develop because of immunologic causes (viral infection, drugs, connective tissue or lymphoproliferative disorders, blood transfusions) or nonimmunologic causes (sepsis... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, <a href="./{1311C574-652C-4899-8901-57241188EEAD}.html" data-toggle="tooltip" title="Urticaria" data-id="3771b9fb-b069-44b3-9d96-7c7306f28deb" data-itemid="1311c574-652c-4899-8901-57241188eead">urticaria</a><span id="3771b9fb-b069-44b3-9d96-7c7306f28deb" class="d-none xref"> <span class="tooltip-container"> <a href="./{1311C574-652C-4899-8901-57241188EEAD}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Urticaria </span> Urticaria consists of migratory, well-circumscribed, erythematous, pruritic plaques on the skin. Urticaria also may be accompanied by angioedema, which results from mast cell and basophil activation... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/s/k/i/skin_lesion_urticaria_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Urticaria" loading="lazy"> </span> </a> </span> </span>, and, rarely, <a href="./{AD5DD1B5-44FC-4A38-A5E5-C1215163B095}.html" data-toggle="tooltip" title="Overview of Thrombotic Disorders" data-id="99c5ffaf-1cb0-4cc7-94ef-a76f8c7a16f3" data-itemid="ad5dd1b5-44fc-4a38-a5e5-c1215163b095">thrombosis</a><span id="99c5ffaf-1cb0-4cc7-94ef-a76f8c7a16f3" class="d-none xref"> <span class="tooltip-container"> <a href="./{AD5DD1B5-44FC-4A38-A5E5-C1215163B095}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Overview of Thrombotic Disorders </span> In healthy people, homeostatic balance exists between procoagulant (clotting) forces and anticoagulant and fibrinolytic forces. Numerous genetic, acquired, and environmental factors can tip... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> and <a href="./{8D10E95E-76C8-49AC-A2F0-4B1FBD198851}.html" data-toggle="tooltip" title="Anaphylaxis" data-id="70babd37-2ffb-450a-a88a-295a9c4b4f03" data-itemid="8d10e95e-76c8-49ac-a2f0-4b1fbd198851">anaphylaxis</a><span id="70babd37-2ffb-450a-a88a-295a9c4b4f03" class="d-none xref"> <span class="tooltip-container"> <a href="./{8D10E95E-76C8-49AC-A2F0-4B1FBD198851}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Anaphylaxis </span> Anaphylaxis is an acute, potentially life-threatening, IgE-mediated allergic reaction that occurs in previously sensitized people when they are reexposed to the sensitizing antigen. Symptoms... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>. Inpatients and possibly outpatients should be screened for bleeding with serial complete blood counts and, where appropriate, testing for occult blood in stool.</p></div> </div> </section> <section id="v45392165" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v45392166" class="anchor"></span> Unfractionated heparin (UFH) </h3> <div class="topic__content"> <span id="v45392167" class="anchor"></span><div class="para"> <p>Unfractionated <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span> may be used instead of LMWH for patients who are hospitalized and for patients who have renal insufficiency or failure (creatinine clearance 10 to 30 mL/minute, (0.17 to 0.5mL/s/m<sup>2</sup>) because UFH is not cleared by the kidneys. UFH is given as a bolus and infusion to achieve full anticoagulation (eg, activated partial thromboplastin time [aPTT] 1.5 to 2.5 times that of the reference range). For outpatients, UFH 333 units/kg initial bolus, then 250 units/kg subcutaneously every 12 hours can be substituted for IV UFH to facilitate mobility; the dose does not need adjustment based on aPTT. If <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>warfarin</span> is used after initial anticoagulation, UFH is continued until full anticoagulation has been achieved with <span class="genericDrug" data-showrollover="false">warfarin</span> (about 5 days).</p></div><span id="v45392169" class="anchor"></span><div class="para"> <p>Complications of UFH are similar to those of LMWHs, except that <a href="./{71EC671B-8559-4245-A3A6-B7AFF664C972}.html#v29269145" data-toggle="tooltip" title="Heparin-induced thrombocytopenia" data-id="d6ef5c4b-49a0-4a93-83af-5a2a7b8b3fe4" data-itemid="71ec671b-8559-4245-a3a6-b7aff664c972"><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span>-induced thrombocytopenia</a><span id="d6ef5c4b-49a0-4a93-83af-5a2a7b8b3fe4" class="d-none xref"> <span class="tooltip-container"> <a href="./{71EC671B-8559-4245-A3A6-B7AFF664C972}.html#v29269145"> <span class="tooltip-content"> <span class="tooltip-heading"> Heparin-induced thrombocytopenia </span> Platelet destruction can develop because of immunologic causes (viral infection, drugs, connective tissue or lymphoproliferative disorders, blood transfusions) or nonimmunologic causes (sepsis... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, which is rare and may be life-threatening, is more common with UFHs. Long-term use of UFH causes <a href="./{2F836CB2-5211-46FB-B1C6-28BB79FC979B}.html" data-toggle="tooltip" title="Hyperkalemia" data-id="ca53f8c9-0ea7-4328-a0a9-cd55cbf39378" data-itemid="2f836cb2-5211-46fb-b1c6-28bb79fc979b">hyperkalemia</a><span id="ca53f8c9-0ea7-4328-a0a9-cd55cbf39378" class="d-none xref"> <span class="tooltip-container"> <a href="./{2F836CB2-5211-46FB-B1C6-28BB79FC979B}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Hyperkalemia </span> Hyperkalemia is a serum potassium concentration > 5.5 mEq/L (> 5.5 mmol/L), usually resulting from decreased renal potassium excretion or abnormal movement of potassium out of cells. There... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, liver enzyme elevations, and osteopenia. Rarely, UFH given subcutaneously causes skin necrosis. Inpatients and possibly outpatients being given UFH should be screened for bleeding.</p></div> </div> </section> <section id="v45392176" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v45392177" class="anchor"></span> Factor Xa inhibitors </h3> <div class="topic__content"> <span id="v45392178" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Rivaroxaban</span> and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>apixaban</span> can be started as monotherapy immediately upon diagnosis or used in transition from an injectable <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span> at any time without overlap. Dosing of <span class="genericDrug" data-showrollover="false">rivaroxaban</span> is 15 mg orally twice a day for 3 weeks followed by 20 mg orally once a day for a total of 3 to 6 months. <span class="genericDrug" data-showrollover="false">Apixaban</span> dosing is 10 mg orally twice a day for 7 days followed by 5 mg orally twice a day for 3 to 6 months. </p></div><span id="v45392179" class="anchor"></span><div class="para"> <p>Before <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>edoxaban</span> is started, an initial 5 to 7 days of treatment with LMWH or UFH is required. Then <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>edoxaban</span> is given 60 mg orally once a day. To transition from an injectable anticoagulant, the <span class="genericDrug" data-showrollover="false">factor Xa</span> inhibitor is typically started within 6 to 12 hours after the last dose of a twice-daily LMWH regimen and within 12 to 24 hours after a once-daily LMWH regimen.</p></div><span id="v45392181" class="anchor"></span><div class="para"> <p>There is evidence that <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>apixaban</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>edoxaban</span>, and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>rivaroxaban</span> can be used in select patients with cancer-associated venous thromboembolism (VTE) as an alternative to monotherapy with LMWH (<a href="./{40A030FA-C405-40DB-867D-6853F28279BE}.html#v37965446" data-toggle="tooltip" title="Treatment references" data-id="70599cea-cf6f-4bf4-904c-78e88f3a3454" data-itemid="40a030fa-c405-40db-867d-6853f28279be">4, 5, 6</a><span id="70599cea-cf6f-4bf4-904c-78e88f3a3454" class="d-none xref"> <span class="tooltip-container"> <a href="./{40A030FA-C405-40DB-867D-6853F28279BE}.html#v37965446"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Deep venous thrombosis (DVT) is clotting of blood in a deep vein of an extremity (usually calf or thigh) or the pelvis. DVT is the primary cause of pulmonary embolism. DVT results from conditions... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/4/3/a/43a-and-43b-doppler-ultrasound-patient-with-a-thrombus-in-femoral-vein-ctisus.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Treatment references" loading="lazy"> </span> </a> </span> </span>). </p></div><span id="v45392183" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Fondaparinux</span>, a parenteral selective <span class="genericDrug" data-showrollover="false">factor Xa</span> inhibitor, may be used as an alternative to UFH or LMWH for the initial treatment of DVT or PE. It is given in a fixed dose of 7.5 mg subcutaneously once a day (10 mg for patients<span class='symbol'> ></span> 100 kg, 5 mg for patients <span class='symbol'>&lt</span> 50 kg). It has the advantage of fixed dosing and is less likely to cause thrombocytopenia.</p></div> </div> </section> <section id="v45392185" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v45392186" class="anchor"></span> Direct thrombin inhibitors </h3> <div class="topic__content"> <span id="v45392187" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Dabigatran</span> 150 mg orally twice a day is given only after an initial 5 days of treatment with LMWH. It is typically started within 6 to 12 hours after the last dose of a twice-daily LMWH regimen and within 12 to 24 hours after a once-daily regimen.</p></div><span id="v45392188" class="anchor"></span><div class="para"> <p>Parenteral direct <span class="genericDrug" data-showrollover="false">thrombin</span> inhibitors (<span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>argatroban</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>bivalirudin</span>, desirudin) are available but do not have a role in treatment or <a href="./{40A030FA-C405-40DB-867D-6853F28279BE}.html#v941221" data-toggle="tooltip" title="Prevention" data-id="a09e9117-a7cb-4388-a6d1-4b3422170192" data-itemid="40a030fa-c405-40db-867d-6853f28279be">prevention</a><span id="a09e9117-a7cb-4388-a6d1-4b3422170192" class="d-none xref"> <span class="tooltip-container"> <a href="./{40A030FA-C405-40DB-867D-6853F28279BE}.html#v941221"> <span class="tooltip-content"> <span class="tooltip-heading"> Prevention </span> Deep venous thrombosis (DVT) is clotting of blood in a deep vein of an extremity (usually calf or thigh) or the pelvis. DVT is the primary cause of pulmonary embolism. DVT results from conditions... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/4/3/a/43a-and-43b-doppler-ultrasound-patient-with-a-thrombus-in-femoral-vein-ctisus.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Prevention" loading="lazy"> </span> </a> </span> </span> of DVT or PE. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Argatroban</span> may be useful to treat DVT in patients with <a href="./{71EC671B-8559-4245-A3A6-B7AFF664C972}.html#v29269145" data-toggle="tooltip" title="Heparin-induced thrombocytopenia" data-id="c81604c0-d435-48e1-9ba1-cb2601fa7ea7" data-itemid="71ec671b-8559-4245-a3a6-b7aff664c972"><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span>-induced thrombocytopenia</a><span id="c81604c0-d435-48e1-9ba1-cb2601fa7ea7" class="d-none xref"> <span class="tooltip-container"> <a href="./{71EC671B-8559-4245-A3A6-B7AFF664C972}.html#v29269145"> <span class="tooltip-content"> <span class="tooltip-heading"> Heparin-induced thrombocytopenia </span> Platelet destruction can develop because of immunologic causes (viral infection, drugs, connective tissue or lymphoproliferative disorders, blood transfusions) or nonimmunologic causes (sepsis... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>.</p></div> </div> </section> <section id="v45392191" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v45392192" class="anchor"></span> Vitamin K antagonists (warfarin) </h3> <div class="topic__content"> <span id="v45392193" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Warfarin</span> is a treatment option for patients with DVT who are not pregnant. It is also an option for patients with severe renal dysfunction. <span class="genericDrug" data-showrollover="false">Warfarin</span> is also a second-line option for patients with cancer-associated VTE. </p></div><span id="v45392194" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Warfarin</span> 5 to 10 mg can be started immediately along with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span> because it takes about 5 days to achieve desired therapeutic effect. Older patients and patients with a liver disorder typically require lower <span class="genericDrug" data-showrollover="false">warfarin</span> doses. Therapeutic goal is an international normalized ratio (INR) of 2.0 to 3.0. INR is monitored weekly for the first 1 to 2 months of <span class="genericDrug" data-showrollover="false">warfarin</span> treatment and monthly thereafter; the dose is increased or decreased by 0.5 to 3 mg to maintain the INR within this range. Patients taking <span class="genericDrug" data-showrollover="false">warfarin</span> should be informed of possible drug interactions, including interactions with foods and nonprescription medicinal herbs.</p></div><span id="v45392195" class="anchor"></span><div class="para"> <p>Rarely, <span class="genericDrug" data-showrollover="false">warfarin</span> causes skin necrosis in patients with inherited <a href="./{9C575C78-50DE-4E82-A630-2B8FD6D5F283}.html" data-toggle="tooltip" title="Protein C Deficiency" data-id="41859d48-8e69-4bae-bbcf-312df23a9bc0" data-itemid="9c575c78-50de-4e82-a630-2b8fd6d5f283">protein C deficiency</a><span id="41859d48-8e69-4bae-bbcf-312df23a9bc0" class="d-none xref"> <span class="tooltip-container"> <a href="./{9C575C78-50DE-4E82-A630-2B8FD6D5F283}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Protein C Deficiency </span> Because activated protein C degrades coagulation factors Va and VIIIa, deficiency of protein C predisposes to venous thrombosis. (See also Overview of Thrombotic Disorders.) Protein C is a vitamin... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> or <a href="./{BB2C9709-6481-457C-8632-F9ABAF438A8B}.html" data-toggle="tooltip" title="Protein S Deficiency" data-id="82988f1d-57cf-42f8-9ff9-5b7dc386ce70" data-itemid="bb2c9709-6481-457c-8632-f9abaf438a8b">protein S deficiency</a><span id="82988f1d-57cf-42f8-9ff9-5b7dc386ce70" class="d-none xref"> <span class="tooltip-container"> <a href="./{BB2C9709-6481-457C-8632-F9ABAF438A8B}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Protein S Deficiency </span> Because protein S binds and assists activated protein C in the degradation of coagulation factors Va and VIIIa, deficiency of protein S predisposes to venous thrombosis. (See also Overview of... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>.</p></div> </div> </section> <section id="v45392198" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v45392199" class="anchor"></span> Anticoagulant treatment references </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v45392202" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="https://journal.chestnet.org/article/S0012-3692(15)00335-9/fulltext">Kearon C, Aki EA, Ornelas J, et al</a>: CHEST Guideline and Expert Panel Report: Antithrombotic therapy for VTE disease. <i>Chest</i> 149:315–352, 2016. doi: https://doi.org/10.1016/j.chest.2015.11.026 </p></div></li><li class="topic__listitem"><span id="v87251681" class="anchor"></span><div class="para"> <p>2. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/17261856/">Segal JB, Streiff MB, Hofmann LV, Thornton K, Bass EB</a>: Management of venous thromboembolism: a systematic review for a practice guideline [published correction appears in <i>Ann Intern Med</i> 2007 Mar 6;146(5):396. Hoffman, Lawrence V [corrected to Hofmann, Lawrence V]]. <i>Ann Intern Med</i> 146(3):211–222, 2007. doi:10.7326/0003-4819-146-3-200702060-00150</p></div></li><li class="topic__listitem"><span id="v87251684" class="anchor"></span><div class="para"> <p>3. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/37266947/">Schrag D, Uno H, Rosovsky R, et al</a>: Direct Oral Anticoagulants vs Low-Molecular-Weight <span class="genericDrug" data-showrollover="false">Heparin</span> and Recurrent VTE in Patients With Cancer: A Randomized Clinical Trial. <i>JAMA</i> 329(22):1924–1933, 2023. doi:10.1001/jama.2023.7843</p></div></li><li class="topic__listitem"><span id="v51698160" class="anchor"></span><div class="para"> <p>4. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/32223112/">Agnelli G, Becattini C, Meyer G, et al</a>: <span class="genericDrug" data-showrollover="false">Apixaban</span> for the treatment of venous thromboembolism associated with cancer. <i>N Engl J Med</i> 382:1599–1607, 2020. doi: 10.1056/NEJMoa1915103 </p></div></li><li class="topic__listitem"><span id="v45392205" class="anchor"></span><div class="para"> <p>5. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/29231094/">Raskob GE, van Es N, Verhamme P, et al</a>: <span class="genericDrug" data-showrollover="false">Edoxaban</span> for the treatment of cancer-associated venous thromboembolism. <i>N Engl J Med</i> Dec 12, 2017. doi: 10.1056/NEJMoa1711948 </p></div></li><li class="topic__listitem"><span id="v45392209" class="anchor"></span><div class="para"> <p>6. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pubmed/29746227">Young AM, Marshall A, Thirlwall J, et al</a>: Comparison of an oral <span class="genericDrug" data-showrollover="false">factor Xa</span> inhibitor with low molecular weight <span class="genericDrug" data-showrollover="false">heparin</span> in patients with cancer with venous thromboembolism: Results of a randomized trial (SELECT-D). <i>J Clin Oncol</i> 36: 2017–2023, 2018. doi: 10.1200/JCO.2018.78.8034</p></div></li></ul></div> </div> </section> </div> </section> <section id="v45392212" class="topic__section FHead"> <h2 id="" class="topic__header--section"> <span id="v45392213" class="anchor"></span> Bleeding During Use of Anticoagulants </h2> <div class="topic__content"> <span id="v45392214" class="anchor"></span><div class="para"> <p>Bleeding is the most common complication of anticoagulants and ranges on a continuum from minor to severe, life-threatening hemorrhage. </p></div><span id="v45392215" class="anchor"></span><div class="para"> <p>For <b>minor bleeding</b> (eg, epistaxis), local measures to stop bleeding (eg, direct pressure) are often sufficient. The anticoagulant is usually not discontinued or reversed unless bleeding becomes more severe.</p></div><span id="v45392216" class="anchor"></span><div class="para"> <p>For <b>severe bleeding</b> (eg, heavy gastrointestinal bleeding), the anticoagulant is usually withheld (at least temporarily) and other measures taken. Bleeding is generally considered severe when it is:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v45392219" class="anchor"></span><div class="para"> <p>Heavy (loss of <span class='symbol'>≥</span> 2 units of blood in <span class='symbol'>≤</span> 7 days)</p></div></li><li class="topic__listitem"><span id="v45392221" class="anchor"></span><div class="para"> <p>In a critical location (eg, intracranial, intraocular)</p></div></li><li class="topic__listitem"><span id="v45392223" class="anchor"></span><div class="para"> <p>In a location where hemostasis is difficult to achieve (eg, small bowel, posterior nasal cavity, lung)</p></div></li></ul></div><span id="v45392224" class="anchor"></span><div class="para"> <p>Risk factors for severe bleeding include </p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v45392227" class="anchor"></span><div class="para"> <p>Age <span class='symbol'>≥</span> 65 years</p></div></li><li class="topic__listitem"><span id="v45392229" class="anchor"></span><div class="para"> <p>History of prior <a href="./{8076A237-C2CC-47F9-821B-E1628309D900}.html" data-toggle="tooltip" title="Overview of Gastrointestinal Bleeding" data-id="d23f3cf7-dbe8-4747-b789-5e35fbd7b539" data-itemid="8076a237-c2cc-47f9-821b-e1628309d900">gastrointestinal bleeding</a><span id="d23f3cf7-dbe8-4747-b789-5e35fbd7b539" class="d-none xref"> <span class="tooltip-container"> <a href="./{8076A237-C2CC-47F9-821B-E1628309D900}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Overview of Gastrointestinal Bleeding </span> Gastrointestinal (GI) bleeding can originate anywhere from the mouth to the anus and can be overt or occult. The manifestations depend on the location and rate of bleeding. (See also Varices... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/7/0/9/709-ct-angiogram-or-vascular-angiography-showing-gi-bleed-springer-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Overview of Gastrointestinal Bleeding" loading="lazy"> </span> </a> </span> </span> or <a href="./{E61C2983-3440-4F96-AA2E-B108231A4E5D}.html" data-toggle="tooltip" title="Overview of Stroke" data-id="a64ac6d9-2bfd-4272-ac44-b400b0b2b8d1" data-itemid="e61c2983-3440-4f96-aa2e-b108231a4e5d">stroke</a><span id="a64ac6d9-2bfd-4272-ac44-b400b0b2b8d1" class="d-none xref"> <span class="tooltip-container"> <a href="./{E61C2983-3440-4F96-AA2E-B108231A4E5D}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Overview of Stroke </span> Strokes are a heterogeneous group of disorders involving sudden, focal interruption of cerebral blood flow that causes neurologic deficit. Strokes can be Ischemic (80%), typically resulting... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/s/u/b/subacute-mca-infarct-ctisus-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Overview of Stroke" loading="lazy"> </span> </a> </span> </span></p></div></li><li class="topic__listitem"><span id="v45392233" class="anchor"></span><div class="para"> <p>Recent <a href="./{1FE201C9-088A-4951-838B-B2C8BB45A77E}.html" data-toggle="tooltip" title="Acute Myocardial Infarction (MI)" data-id="3bd25f98-3f39-4e1f-a4b7-b86c2561eca0" data-itemid="1fe201c9-088a-4951-838b-b2c8bb45a77e">myocardial infarction</a><span id="3bd25f98-3f39-4e1f-a4b7-b86c2561eca0" class="d-none xref"> <span class="tooltip-container"> <a href="./{1FE201C9-088A-4951-838B-B2C8BB45A77E}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Acute Myocardial Infarction (MI) </span> Acute myocardial infarction is myocardial necrosis resulting from acute obstruction of a coronary artery. Symptoms include chest discomfort with or without dyspnea, nausea, and/or diaphoresis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/6/0/0/600-nstemi-s192-springer-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Acute Myocardial Infarction (MI)" loading="lazy"> </span> </a> </span> </span></p></div></li><li class="topic__listitem"><span id="v45392236" class="anchor"></span><div class="para"> <p>Coexisting anemia (hematocrit <span class='symbol'>&lt</span> 30%), renal insufficiency (serum creatinine <span class='symbol'>></span> 1.5 mg/dL [115 micromol/L]), or diabetes</p></div></li></ul></div><span id="v45392237" class="anchor"></span><div class="para"> <p><b>Supportive care</b> for severe bleeding includes local measures to stop bleeding (eg, direct pressure, cauterization, injection). Patients with signs and symptoms of volume loss and those with heavy ongoing bleeding may require <a href="./{172E4EAF-CAEA-4939-8AAD-CD0531B38B78}.html" data-toggle="tooltip" title="Intravenous Fluid Resuscitation" data-id="00a8ec50-c815-4c98-8288-95662c8ac84e" data-itemid="172e4eaf-caea-4939-8aad-cd0531b38b78">intravenous fluid resuscitation</a><span id="00a8ec50-c815-4c98-8288-95662c8ac84e" class="d-none xref"> <span class="tooltip-container"> <a href="./{172E4EAF-CAEA-4939-8AAD-CD0531B38B78}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Intravenous Fluid Resuscitation </span> Almost all circulatory shock states require large-volume IV fluid replacement, as does severe intravascular volume depletion (eg, due to diarrhea or heatstroke). Intravascular volume deficiency... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> and <a href="./{42A22707-FB40-4C1B-8A0E-85EF5F690242}.html#v976886" data-toggle="tooltip" title="Red blood cells (RBCs)" data-id="6e9a8273-8c08-478b-817c-abffd394cccb" data-itemid="42a22707-fb40-4c1b-8a0e-85ef5f690242">packed red blood cell transfusions</a><span id="6e9a8273-8c08-478b-817c-abffd394cccb" class="d-none xref"> <span class="tooltip-container"> <a href="./{42A22707-FB40-4C1B-8A0E-85EF5F690242}.html#v976886"> <span class="tooltip-content"> <span class="tooltip-heading"> Red blood cells (RBCs) </span> Whole blood can provide improved oxygen-carrying capacity, volume expansion, and replacement of clotting factors and was previously recommended for rapid massive blood loss. However, because... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>. These measures are sufficient for many bleeding episodes.</p></div><span id="v45392240" class="anchor"></span><div class="para"> <p>In patients with <b>life-threatening and/or ongoing bleeding</b> or <b>bleeding in a critical location,</b> clinicians also consider giving</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v45392243" class="anchor"></span><div class="para"> <p>Reversal agents</p></div></li><li class="topic__listitem"><span id="v45392245" class="anchor"></span><div class="para"> <p>Clotting factors (eg, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>prothrombin complex concentrate</span>, fresh frozen plasma)</p></div></li><li class="topic__listitem"><span id="v45392247" class="anchor"></span><div class="para"> <p>Antifibrinolytics</p></div></li></ul></div><span id="v45392248" class="anchor"></span><div class="para"> <p>However, by definition these agents are prothrombotic and the risks of continued bleeding should be balanced with the increased risk of thrombosis.</p></div> <section id="v45392249" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v45392250" class="anchor"></span> Anticoagulant reversal </h3> <div class="topic__content"> <span id="v45392251" class="anchor"></span><div class="para"> <p>Many of the anticoagulants have specific reversal agents. If these are unavailable or ineffective, clotting factors, typically in the form of 4-factor <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>prothrombin complex concentrate</span> or sometimes fresh frozen plasma, can be given. Some anticoagulants can be removed by hemodialysis or have absorption blocked by activated <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>charcoal</span>.</p></div><span id="v45392252" class="anchor"></span><div class="para"> <p>With the <b>heparins,</b> bleeding can be stopped or slowed with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>protamine</span>. It is more effective on UFH than on LMWH because <span class="genericDrug" data-showrollover="false">protamine</span> only partially neutralizes LMWH inactivation of <span class="genericDrug" data-showrollover="false">factor Xa</span>. The dose is 1 mg <span class="genericDrug" data-showrollover="false">protamine</span> for each 100 units of UFH given or for each milligram of LMWH; <span class="genericDrug" data-showrollover="false">protamine</span> is infused slowly over 10 to 20 minutes (maximum dose 50 mg in 10 minutes). The dose is lowered depending on the time since UFH was given. If a 2nd dose is required, it should be one half the first dose. During all infusions, patients should be observed for hypotension and a reaction similar to an anaphylactic reaction. Because UFH given IV has a half-life of 30 to 60 minutes, <span class="genericDrug" data-showrollover="false">protamine</span> is typically not given to patients who have received UFH <span class='symbol'>></span> 60 to 120 minutes beforehand) or is given at a reduced dose based on the amount of <span class="genericDrug" data-showrollover="false">heparin</span> estimated to be remaining in plasma, based on the half-life of UFH.</p></div><span id="v45392253" class="anchor"></span><div class="para"> <p><b><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Warfarin</span></b> anticoagulation can be reversed with vitamin K; the dose is 1 to 2.5 mg orally if INR is 5 to 9, 2.5 to 5 mg orally if INR is <span class='symbol'>></span> 9, and 5 to 10 mg IV (given slowly to avoid anaphylaxis) if there is active hemorrhage. If hemorrhage is severe, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>prothrombin complex concentrate</span> should be given; fresh frozen plasma may be used if <span class="genericDrug" data-showrollover="false">prothrombin complex concentrate</span> is unavailable. Selected patients with overanticoagulation (INR 5 to 9) who are neither actively bleeding nor at increased risk of bleeding can be managed by omitting 1 or 2 <span class="genericDrug" data-showrollover="false">warfarin</span> doses and monitoring INR more frequently, then giving <span class="genericDrug" data-showrollover="false">warfarin</span> at a lower dose. </p></div><span id="v45392254" class="anchor"></span><div class="para"> <p>With <b><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>dabigatran</span>,</b> a humanized monoclonal antibody <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>idarucizumab</span> 5 g IV is an effective antidote to bleeding. If the agent is not available, 4-factor <span class="genericDrug" data-showrollover="false">prothrombin complex concentrate</span> 50 units/kg IV can be given. <a href="./{8DD687E6-CFB0-42BE-8253-4652EE450453}.html" data-toggle="tooltip" title="Hemodialysis" data-id="6263d5e1-ddbc-4904-9da1-7dc54dd9a07f" data-itemid="8dd687e6-cfb0-42be-8253-4652ee450453">Hemodialysis</a><span id="6263d5e1-ddbc-4904-9da1-7dc54dd9a07f" class="d-none xref"> <span class="tooltip-container"> <a href="./{8DD687E6-CFB0-42BE-8253-4652EE450453}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Hemodialysis </span> In hemodialysis, a patient’s blood is pumped into a dialyzer containing 2 fluid compartments configured as bundles of hollow fiber capillary tubes or as parallel, sandwiched sheets of semipermeable... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> also may help because <span class="genericDrug" data-showrollover="false">dabigatran</span> is not highly protein bound. Oral activated <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>charcoal</span> is an option if the last dose of <span class="genericDrug" data-showrollover="false">dabigatran</span> was within 2 hours.</p></div><span id="v45392256" class="anchor"></span><div class="para"> <p>With <b><span class="genericDrug" data-showrollover="false">factor Xa</span> inhibitors,</b> andexanet alfa is an antidote available in the United States; however, its use is restricted in part due to its high cost (<a href="./{99F36709-190D-404E-BF6D-A0B1F6A706F0}.html#v45392280" data-toggle="tooltip" title="Bleeding due to anticoagulants reference" data-id="684d271c-e462-4591-889d-ad8779c619fe" data-itemid="99f36709-190d-404e-bf6d-a0b1f6a706f0">1</a><span id="684d271c-e462-4591-889d-ad8779c619fe" class="d-none xref"> <span class="tooltip-container"> <a href="./{99F36709-190D-404E-BF6D-A0B1F6A706F0}.html#v45392280"> <span class="tooltip-content"> <span class="tooltip-heading"> Bleeding due to anticoagulants reference </span> Almost all patients with deep venous thrombosis (DVT) are given anticoagulants and in rare cases thrombolytics. A number of anticoagulants are effective for management of deep venous thrombosis... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). If the patient is on a high dose of a <span class="genericDrug" data-showrollover="false">factor Xa</span> inhibitor (eg, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>rivaroxaban</span> > 10 mg or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>apixaban</span> > 5 mg), or if the patient took the medication <span class='symbol'>&lt</span> 8 hours before presentation, a high dose of <span class="genericDrug" data-showrollover="false">andexanet alfa</span> (800 mg IV at 30 mg/minute followed by 960 mg IV at 8 mg/minute) is given. If the patient is on a low dose of a <span class="genericDrug" data-showrollover="false">factor Xa</span> inhibitor or took the medication > 8 hours before presentation, a lower dose of <span class="genericDrug" data-showrollover="false">andexanet alfa</span> (400 mg IV at 30 mg/minute followed by 480 mg IV at 8 mg/minute) is given. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Fondaparinux</span> anticoagulation can theoretically be reversed with <span class="genericDrug" data-showrollover="false">andexanet alfa</span> although this has not been studied in research trials. If <span class="genericDrug" data-showrollover="false">andexanet alfa</span> is unavailable, 4-factor <span class="genericDrug" data-showrollover="false">prothrombin complex concentrate</span> may be considered. Oral activated <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>charcoal</span> is an option in patients who took an oral <span class="genericDrug" data-showrollover="false">factor Xa</span> inhibitor within a few hours of presentation (8 hours for <span class="genericDrug" data-showrollover="false">rivaroxaban</span>, 6 hours for <span class="genericDrug" data-showrollover="false">apixaban</span>, and 2 hours for <span class="genericDrug" data-showrollover="false">edoxaban</span>). Hemodialysis is not effective for removal of the oral <span class="genericDrug" data-showrollover="false">factor Xa</span> inhibitors. </p></div><span id="v45392258" class="anchor"></span><div class="para"> <p>Other reversal agents for direct oral anticoagulants are currently being developed (eg, ciraparantag). </p></div> </div> </section> <section id="v45392259" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v45392260" class="anchor"></span> Clotting factors </h3> <div class="topic__content"> <span id="v45392261" class="anchor"></span><div class="para"> <p>Clotting factors are available in the form of </p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v45392264" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Prothrombin complex concentrate</span></p></div></li><li class="topic__listitem"><span id="v45392266" class="anchor"></span><div class="para"> <p>Fresh frozen plasma</p></div></li><li class="topic__listitem"><span id="v45392268" class="anchor"></span><div class="para"> <p>Individual clotting factors</p></div></li></ul></div><span id="v45392269" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Prothrombin complex concentrate</span> (PCC) is available in several forms. Three-factor PCC contains high levels of factors II, IX, and X, and 4-factor PCC adds factor VII; both also have proteins C and S. PCCs can be unactivated, or activated, in which some of the factors have been cleaved to the active form. The 4-factor PCC is preferred as it tends to be more effective at reversing bleeding than 3-factor PCC. If 3-factor PCC is used, fresh frozen plasma (FFP) can also be given because FFP contains factor VII, which is not contained in 3-factor PCC. Typical dose is 50 units/kg IV. Because evidence of benefit is uncertain and risk of clotting is significant, PCCs should be reserved for life-threatening bleeding.</p></div><span id="v45392270" class="anchor"></span><div class="para"> <p>Fresh frozen plasma contains all the clotting factors but only at normal plasma levels. It is now typically used only if PCC is unavailable; there is no evidence it is effective in bleeding due to <span class="genericDrug" data-showrollover="false">factor Xa</span> inhibitors</p></div><span id="v45392271" class="anchor"></span><div class="para"> <p>Individual clotting factors such as activated recombinant factor VII are available but are not thought to be helpful for anticoagulant-related bleeding.</p></div> </div> </section> <section id="v45392272" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v45392273" class="anchor"></span> Antifibrinolytics and other agents </h3> <div class="topic__content"> <span id="v45392274" class="anchor"></span><div class="para"> <p>Antifibrinolytic agents can also be tried; however, their use has not been studied for reversal of bleeding in patients taking anticoagulants. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Tranexamic acid</span> 10 to 20 mg/kg IV bolus followed by 10 mg/kg IV every 6 to 8 hours may be used. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Aminocaproic acid</span> may be started at 2 gm IV every 6 hours.</p></div> </div> </section> <section id="v45392275" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v45392276" class="anchor"></span> Resumption of anticoagulation after bleeding </h3> <div class="topic__content"> <span id="v45392277" class="anchor"></span><div class="para"> <p>Clinical judgment is necessary when deciding whether to permanently stop or lower the dose of anticoagulant.</p></div><span id="v45392278" class="anchor"></span><div class="para"> <p>If a patient has almost completed their treatment course of anticoagulant and has a severe bleeding episode, the anticoagulant can be stopped. However, if a patient has just started or is mid-way through their treatment course and has a severe bleed, the decision of whether to stop or reduce the dose of anticoagulant is not as straightforward and should be made in consultation with a multidisciplinary team and keeping in mind the patient's priorities.</p></div> </div> </section> <section id="v45392279" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v45392280" class="anchor"></span> Bleeding due to anticoagulants reference </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v45392283" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pubmed/30730782">Connolly SJ, Crowther M, Eikelboom JW, et al</a>: Full study report of <span class="genericDrug" data-showrollover="false">andexanet alfa</span> for bleeding associated with <span class="genericDrug" data-showrollover="false">factor Xa</span> inhibitors. <i>N Engl J Med</i> 380:1326–1335, 2019. doi: 10.1056/NEJMoa1814051</p></div></li></ul></div> </div> </section> </div> </section> <section id="v45392286" class="topic__section FHead"> <h2 id="" class="topic__header--section"> <span id="v45392287" class="anchor"></span> Thrombolytic (Fibrinolytic) Agents </h2> <div class="topic__content"> <span id="v45392288" class="anchor"></span><div class="para"> <p>Thrombolytic agents, which include <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>alteplase</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tenecteplase</span>, and streptokinase, lyse clots and may be more effective than <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span> alone in selected patients with DVT, but the risk of bleeding is higher than with <span class="genericDrug" data-showrollover="false">heparin</span> alone. For patients with DVT, a clinical trial showed that catheter-directed thrombolytic therapy did not reduce the incidence of post-thrombotic syndrome compared with conventional anticoagulant therapy (<a href="./{99F36709-190D-404E-BF6D-A0B1F6A706F0}.html#v45392296" data-toggle="tooltip" title="Thrombolytic treatment reference" data-id="256b372f-d9aa-4653-acff-a90d7aa1ce8a" data-itemid="99f36709-190d-404e-bf6d-a0b1f6a706f0">1</a><span id="256b372f-d9aa-4653-acff-a90d7aa1ce8a" class="d-none xref"> <span class="tooltip-container"> <a href="./{99F36709-190D-404E-BF6D-A0B1F6A706F0}.html#v45392296"> <span class="tooltip-content"> <span class="tooltip-heading"> Thrombolytic treatment reference </span> Almost all patients with deep venous thrombosis (DVT) are given anticoagulants and in rare cases thrombolytics. A number of anticoagulants are effective for management of deep venous thrombosis... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). Consequently, thrombolytic agents should be considered only in highly selected patients with DVT. Patients who may benefit from thrombolytic agents include those with extensive iliofemoral DVT who are younger (<span class='symbol'>&lt</span> 60 years) and do not have risk factors for bleeding. Thrombolytic therapy should be given stronger consideration in patients with extensive DVT who have evolving or existing limb ischemia (eg, phlegmasia cerulea dolens).</p></div><span id="v45392290" class="anchor"></span><div class="para"> <p>For patients with PE, thrombolytic therapy should be considered if patients have clinically massive PE, defined as PE associated with systemic hypotension (systolic blood pressure <span class='symbol'>&lt</span> 90 mm Hg), <a href="./{325CC6A6-C2A7-4B95-A6DC-7BB5B819D97F}.html#v928088" data-toggle="tooltip" title="Cardiogenic and obstructive shock" data-id="857747c6-3e0d-4d85-a0bb-de4ebcbcbe15" data-itemid="325cc6a6-c2a7-4b95-a6dc-7bb5b819d97f">cardiogenic shock</a><span id="857747c6-3e0d-4d85-a0bb-de4ebcbcbe15" class="d-none xref"> <span class="tooltip-container"> <a href="./{325CC6A6-C2A7-4B95-A6DC-7BB5B819D97F}.html#v928088"> <span class="tooltip-content"> <span class="tooltip-heading"> Cardiogenic and obstructive shock </span> Shock is a state of organ hypoperfusion with resultant cellular dysfunction and death. Mechanisms may involve decreased circulating volume, decreased cardiac output, and vasodilation, sometimes... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, or <a href="./{A3683904-07B7-4347-AE9E-4A20EA415D58}.html" data-toggle="tooltip" title="Overview of Respiratory Failure" data-id="986d7f65-8db8-4bee-b47a-f9a67211cdeb" data-itemid="a3683904-07b7-4347-ae9e-4a20ea415d58">respiratory failure</a><span id="986d7f65-8db8-4bee-b47a-f9a67211cdeb" class="d-none xref"> <span class="tooltip-container"> <a href="./{A3683904-07B7-4347-AE9E-4A20EA415D58}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Overview of Respiratory Failure </span> Acute respiratory failure is a life-threatening impairment of oxygenation, carbon dioxide elimination, or both. Respiratory failure may occur because of impaired gas exchange, decreased ventilation... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>. Most other patients, with submassive PE, do not appear to benefit from thrombolytic therapy. However, in selected patients with submassive PE, thrombolytic therapy may be considered if there is clinical deterioration despite conventional anticoagulant therapy. In patients with submassive PE and right ventricular dysfunction, thrombolytic therapy should not be routinely used. </p></div><span id="v45392293" class="anchor"></span><div class="para"> <p>For either DVT or PE, available evidence comparing local (ie, catheter-directed) with systemic administration of thrombolytic therapy has not shown a clear benefit of either modality with respect to mortality. </p></div><span id="v45392294" class="anchor"></span><div class="para"> <p>Bleeding, if it occurs, is most often at the site of arterial or venous puncture sites. This complication can be treated by stopping the thrombolytic agent and doing mechanical compression or surgical repair of the puncture site. Life-threatening bleeding is treated with cryoprecipitate and fresh frozen plasma in addition to stopping the thrombolytic agent.</p></div> <section id="v45392295" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v45392296" class="anchor"></span> Thrombolytic treatment reference </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v45392299" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pubmed/29211671">Vedantham S, Goldhaber SZ, Julien JA, et al</a>: Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis. <i>N Engl J Med</i> 377:2240–2252, 2017. doi: 10.1056/NEJMoa1615066</p></div></li></ul></div> </div> </section> </div> </section> <section id="v87251714" class="topic__section FHead"> <h2 id="" class="topic__header--section"> <span id="v87251715" class="anchor"></span> More Information </h2> <div class="topic__content"> <span id="v87251716" class="anchor"></span><div class="para"> <p>The following English-language resource may be useful. Please note that THE MANUAL is not responsible for the content of this resource.</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v87251719" class="anchor"></span><div class="para"> <p><a rel="nofollow" target="_blank" href="https://journal.chestnet.org/article/S0012-3692(15)00335-9/fulltext">Kearon C, Aki EA, Ornelas J, et al</a>: CHEST Guideline and Expert Panel Report: Antithrombotic therapy for VTE disease. <i>Chest</i> 149:315–352, 2016. doi: https://doi.org/10.1016/j.chest.2015.11.026 </p></div></li></ul></div> </div> </section>
 
 <section class="topic__section">
 <div class="topicswitch topic__patient-education topic__patient-education--bottom hide-on-print" data-icd9="MM1240">
 <div class="topic__patient-education--container">
 <div class="topic__patient-education--icon"></div>
 <div class="topic__patient-education--text">
 View PATIENT EDUCATION
 </div>
 </div>
 </div>
 </section>
</div>
<script type="text/javascript">
 $(document).ready(function () {
 $(document).on('click', '.topicswitch', function (e) {
 e.preventDefault();
 $.ajax({
 url: '/Custom/Edition/GetSwitchUrl',
 type: "GET",
 dataType: "json",
 data: {
 icd9: 'MM1240',
 title: 'Medications for Deep Venous Thrombosis',
 itemGuid: '99f36709-190d-404e-bf6d-a0b1f6a706f0'
 }
 }).done(function (data) {
 
 // redirect
 location.href = data.href;
 }).fail(function (jqxhr, textStatus, errorThrown) {
 console.error(errorThrown);
 });
 });
 });
</script>
 </article>
 <div class="copyright-print">
 <div class="copyright-print--logo">
<img src="./Content/Images/msd_foot_logo.png" alt="" class="badge msd" loading="lazy" width="240" height="71">
 </div>
 <div class="copyright-print--text">
 Copyright © 2024 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.
 </div>
 </div>
 <section class="bottomnav__wrapper hide-on-print" style="display:none">
 
<div class="bottomnav no-print side-by-side">
 <div class="bottomnav__gotolink bottomnav__gotolink--previous">
 <a href="./{40A030FA-C405-40DB-867D-6853F28279BE}.html">
 <div class="bottomnav__gotolink--content">
 <div class="bottomnav__icon bottomnav__icon--previous"></div>
 <div class="bottomnav__linktext">Deep Venous Thrombosis (DVT)</div>
 </div>
 </a>
 </div>
 
 <div class="bottomnav__gotolink bottomnav__gotolink--next">
 <a href="./{A0208929-4490-4FFF-BF77-44F567A35AAB}.html">
 <div class="bottomnav__gotolink--content">
 <div class="bottomnav__linktext">Deep Venous Thrombosis (DVT) Prevention</div>
 <div class="bottomnav__icon bottomnav__icon--next"></div>
 </div>
 </a>
 </div>
</div>
 </section>
</div>
<span id="showpopup"></span>
<span id="showchildpopup"></span>
<div class="box box--marketing marketing-block orderize__candidate hide-on-print" data-orderize="1301">
 <div class="marketing-block-wrapper">
 <div class="box__header">
 <div class="box__headertext"></div>
 </div>
 <div class="box__content">
<div class="marketingblock-quiz hide-on-print">
<div class="marketingblock-quiz-img">
<img alt="quiz link" src="./Content/Images/Redesign/quizzes_lightbulb_red.png" loading="lazy" width="64" height="52">
</div>
<div class="marketingblock-quiz-desc">
<h4>Test your knowledge</h4>
<a href="./{976709AA-1FDC-4953-8B32-2A9E9973AC21}.html">Take a Quiz! </a></div>
</div> </div>
 </div>
</div>
<script type="text/javascript">
 $('img[usemap]').rwdImageMaps();
</script>
<div class="box box--marketing marketing-block orderize__candidate hide-on-print" data-orderize="1550">
 <div class="marketing-block-wrapper">
 <div class="box__header">
 <div class="box__headertext"></div>
 </div>
 <div class="box__content">
 <div class="box__content--mobile">
 <img loading="lazy" src="./~/media/manual/marketing/mobileqr/en_msd_mobile_pro_326.gif" alt="" id="bacad913-28b5-49b0-8c86-ae766abf227a_mobile" usemap="#bacad913-28b5-49b0-8c86-ae766abf227a_mobile" width="326" height="90">
 <map name="bacad913-28b5-49b0-8c86-ae766abf227a_mobile">
 <area shape="RECT" coords="176,79,90,53" href="https://play.google.com/store/apps/details?id=com.msd.professional&referrer=utm_source%3DMMWeb%26utm_medium%3Dbanner%26utm_content%3DTopic1Vertical%26utm_campaign%3DWebAppAds" target="_blank" alt="iOS">
<area shape="RECT" coords="202,51,297,80" href="https://apps.apple.com/app/msd-professional-version/id1123678257" target="_blank" alt="ANDROID">
 </map>
 </div>
 <div class="box__content--tablet">
 <img loading="lazy" src="./~/media/manual/marketing/mobileqr/en_msd_mobile_pro_326.gif" alt="" id="bacad913-28b5-49b0-8c86-ae766abf227a_tablet" usemap="#bacad913-28b5-49b0-8c86-ae766abf227a_tablet" width="326" height="90">
 <map name="bacad913-28b5-49b0-8c86-ae766abf227a_tablet">
 <area shape="RECT" coords="176,79,90,53" href="https://play.google.com/store/apps/details?id=com.msd.professional&referrer=utm_source%3DMMWeb%26utm_medium%3Dbanner%26utm_content%3DTopic1Vertical%26utm_campaign%3DWebAppAds" target="_blank" alt="iOS">
<area shape="RECT" coords="202,51,297,80" href="https://apps.apple.com/app/msd-professional-version/id1123678257" target="_blank" alt="ANDROID">
 </map>
 </div>
 <div class="box__content--desktop">
 <img loading="lazy" src="./~/media/manual/marketing/mobileqr/en_msd_mobile_qr_pro_326.gif" alt="" id="bacad913-28b5-49b0-8c86-ae766abf227a_desktop" usemap="#bacad913-28b5-49b0-8c86-ae766abf227a_desktop" width="326" height="90">
 <map name="bacad913-28b5-49b0-8c86-ae766abf227a_desktop">
 <area shape="RECT" coords="176,79,90,53" href="https://apps.apple.com/app/msd-professional-version/id1123678257" target="_blank" alt="iOS">
<area shape="RECT" coords="202,51,297,80" href="https://play.google.com/store/apps/details?id=com.msd.professional&referrer=utm_source%3DMMWeb%26utm_medium%3Dbanner%26utm_content%3DTopic1Vertical%26utm_campaign%3DWebAppAds" target="_blank" alt="ANDROID">
 </map>
 </div>
 </div>
 </div>
</div>
<script type="text/javascript">
 $('img[usemap]').rwdImageMaps();
</script>
<a id="autoload" role="button" tabindex="-1"></a>
 <div class="autoload-placeholder hide-on-print" name="Up Next:"></div>
 <a class="next-topic hide-on-print" role="button" aria-hidden="true"></a>
 </div>
</div>
 </section>
 
 </main>
 
 <div class="l-layer l-layer--topscroll">
 <div class="topscroll topscroll--hidden">
 <div class="topscroll__container">
 <div class="topscroll__button">
 <div class="topscroll__content">
 <i class="topscroll__arrow"></i>
 TOP
 </div>
 </div>
 </div>
 <div class="topscroll__bar"></div>
</div>
 </div>
 </div>
 
 <div class="flyout hide-on-print" tabindex="0">
 <nav class="flyout__menu" role="application" aria-label="Menu">
 </nav>
 </div>
 <div class="print">
 <div id="print__content">
 </div>
 </div>
 <div class="multimedia__popup l-viewport" data-bind="component: { name: 'multimedia-popup'}">
 <!-- Placeholder for media players. -->
</div>
 <script type="text/javascript">
 //global value for translating the 'Read More' value
 var MMReadMore = "read more";
 var MMMaxTeaseCount = 250;
 </script>
 
 
<div class="sticky-footer hide-on-print">
 <ul>
 <li class="sticky-footer--topic">
 <button aria-label="Topic" class="sticky-footer-topicmenu" aria-expanded="false">
 <span class="footer-bar__icon topic-ico"></span>
 </button>
 <div class="footer-expand-cont footer-parent-cont topicList">
 <button aria-label="close" class="footer-expand-cont__close"></button>
 <div class="footer-topicList-wrapper">
 <div class="in-this-topic-sidebar">
 <div class="box__header">
 <span>IN THIS TOPIC</span>
 <span class="in-this-topic-togggle-btn" aria-label="IN THIS TOPIC" aria-expanded="false"></span>
 </div>
 </div>
 </div>
 </div>
 </li>
 <li class="sticky-footer--version-switcher nontopicpage">
 <a data-id="HE" href="/home" target="_self" aria-label="Version Switch">
 <span class="footer-bar__icon versionSwitcher-ico"></span>
 </a>
 </li>
 <li class="sticky-footer--version-switcher topicpage">
 <a class="topicswitch" href="#" target="_self" aria-label="Version Switch">
 <span class="footer-bar__icon versionSwitcher-ico"></span>
 </a>
 </li>
 <li class="sticky-footer--vetFilter"></li>
 <li>
 <a href="./{218352E5-01E6-4C81-9542-33CF998B22E9}.html" target="_self" aria-label="Resources">
 <span class="footer-bar__icon resources-ico"></span>
 </a>
 </li>
 <li class="sticky-footer--social">
 <aside class="actiontoolbar hide-on-print">
 <!--<a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--bookmark" onclick="bookmarkPage(this);" href="#"></a>-->
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--download" style="display: none" href="#"></a>
 
 <ul>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--share a2a_dd" href="https://www.addtoany.com/share" rel="noopener" role="button" aria-expanded="false" aria-label="Share in"></a>
 </li>
 <li>
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--print" href="#" onclick="window.print(); MManual.analytics.notifyOpenModal(MManual.analytics.eventPrintAnArticle);" role="button" title="print"></a>
 </li>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--email a2a_button_email" href="#" role="button" title="Mail"></a>
 </li>
 <li class="scroll-to-top">
 <a href="#top" role="button" aria-label="Go To Top" title="Go To Top"><span class="scroll-to-top-img"></span></a>
 </li>
 <li class="scroll-to-bottom">
 <a href="#" role="button" aria-label="Go To Top"><span class="scroll-to-bottom-img"></span></a>
 </li>
 </ul>
 </aside>
 </li>
 <li class="sticky-footer--moreCont">
 <button aria-label="More" class="sticky-footer--more" aria-expanded="false">
 <span class="footer-bar__icon more-ico"></span>
 </button>
 <div class="footer-expand-cont more-footer-container">
 <ul>
 <li>
 <a href="./{F01A9F26-96C0-45E2-8ACC-403ACDB78022}.html" target="_self" aria-label="Home">
 <span class="footer-bar__icon home-ico"></span>
 </a>
 </li>
 <li>
 <a href="./{FF41B506-E267-4A7F-8357-F8C0474115E2}.html" target="_self" aria-label="info">
 <span class="footer-bar__icon info-ico"></span>
 </a>
 </li>
 <li>
 <button aria-label="Settings" aria-expanded="false">
 <span class="footer-bar__icon settings-ico"></span>
 </button>
 <div class="footer-sub-cont settings-footer-cont"></div>
 </li>
 <li class="language-footer">
 <button aria-label="Select Language" aria-expanded="false">
 <span class="footer-bar__icon language-ico"></span>
 </button>
 <div class="footer-sub-cont language-footer-cont"></div>
 </li>
 </ul>
 </div>
 </li>
 </ul>
</div>
 
 
 
<!--[if (gte IE 9)|!(IE)]><!-->
<script type="text/javascript">
 function downloadJSAtOnload() {
 
 MManual.deferredScripts.push("./bundles/redesign/libsdeferredjsv4.1.2.2-13178e13ca.js?v=0HKp-yFnKaDEueCLP27J6D4rHb3-AAxm6cmzEE3Gmb41");
 
 
 MManual.deferredScripts.push("./bundles/redesign/mmanualdeferredjsv4.1.2.2-13178e13ca.js?v=-hMvtQA9NJy1WdyRhBfBFzrPaWL44SkinQI4pIY9AWk1");
 
 
 MManual.deferredScripts.push("./bundles/redesign/mmanualTopicdeferredjsv4.1.2.2-13178e13ca.js?v=wDzP134aC3i-5gwHvRAsARMyhcs_em3XWcSsRyzYpYQ1");
 
 MManual.utils.loadScripts(MManual.deferredScripts);
 }
 $(document).ready(downloadJSAtOnload);
</script>
<!--<![endif]-->
<!--[if lt IE 9]>
 
 <script src="/Content/Scripts/Lib/mediaelement-and-player.min.js?v4.1.2.2-13178e13ca" type="text/javascript"></script>
 <script src="/Content/Scripts/Lib/zoomerang.js?v4.1.2.2-13178e13ca" type="text/javascript"></script>
 <script type="text/javascript">
 function downloadJSAtOnload() {
 
 MManual.deferredScripts.push("/bundles/redesign/mmanualdeferredjsv4.1.2.2-13178e13ca.js?v=-hMvtQA9NJy1WdyRhBfBFzrPaWL44SkinQI4pIY9AWk1");
 
 
 MManual.deferredScripts.push("/bundles/redesign/ie8libsdeferredjsv4.1.2.2-13178e13ca.js?v=0HKp-yFnKaDEueCLP27J6D4rHb3-AAxm6cmzEE3Gmb41");
 
 
 MManual.deferredScripts.push("/bundles/redesign/mmanualTopicdeferredjsv4.1.2.2-13178e13ca.js?v=wDzP134aC3i-5gwHvRAsARMyhcs_em3XWcSsRyzYpYQ1");
 
 for (var i = 0; i < MManual.deferredScripts.length; i++) {
 var element = document.createElement("script");
 element.src = MManual.deferredScripts[i];
 element.classList.add("optanon-category-C0002");
 document.body.appendChild(element);
 }
 }
 $(document).ready(downloadJSAtOnload);
 </script>
<![endif]-->
 <!-- Current instance name : ue-p-sc-cd04
 Current application version : 4.1.2.2-13178e13ca
 -->
 <!--[if (gte IE 9)|!(IE)]><!-->
<script src="./bundles/redesign/libsEndjsv4.1.2.2-13178e13ca.js?v=NWrOPHpqntlKhYlvryw8nEPZpRaWQrScEY3i127KnfI1"></script>
<!--<![endif]-->
<input id="MediaFramework_ItemId" name="MediaFramework_ItemId" type="hidden" value="99F36709190D404EBF6DA0B1F6A706F0">
<div id="hiddentblcontents" style="display:none"><div id='hidden_v45392065'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v45392066"></span> <div class="TableFullPage" id="v45392065"> <h3 class="title">Direct Oral Anticoagulants for Treatment of Venous Thromboembolism</h3> <div class="tableWrapper"> <table> <thead><tr><th style='text-align:left' scope='col'><span id="v45392074" class="anchor"></span><div class="para"> <p>Medication</p></div></th><th style='text-align:left' scope='col'><span id="v45392076" class="anchor"></span><div class="para"> <p>Dose</p></div></th><th style='text-align:left' scope='col'><span id="v45392078" class="anchor"></span><div class="para"> <p>Comments</p></div></th></tr></thead> <tbody><tr class="odd" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v45392087" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Factor Xa</span> inhibitors</p></div></p></td><td><span id="v45392089" class="anchor"></span><div class="para"> <p></div></td></tr><tr class="even"><td><span id="v45392092" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Apixaban</span></p></div></td><td><span id="v45392094" class="anchor"></span><div class="para"> <p>10 mg twice a day for 7 days</p></div><span id="v45392095" class="anchor"></span><div class="para"> <p>Then 5 mg twice a day</p></div></td><td><span id="v45392097" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Apixaban</span> should not be used for DVT or PE if creatinine clearance is <span class='symbol'></span> 30 mL/minute (0.5mL/s/m<sup>2</sup>).</p></div><span id="v45392098" class="anchor"></span><div class="para"> <p>Dosage may be lowered to 2.5 mg twice a day after 6–12 months of treatment.</p></div></td></tr><tr class="odd"><td><span id="v45392109" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Edoxaban</span></p></div></td><td><span id="v45392111" class="anchor"></span><div class="para"> <p>60 mg once a day</p></div><span id="v45392112" class="anchor"></span><div class="para"> <p>If creatinine clearance is 15–50 mL/minute (0.25 to 0.83 mL/s/m<sup>2</sup>) or if body weight is <span class='symbol'>≤</span> 60 kg, 30 mg once a day</p></div></td><td><span id="v45392114" class="anchor"></span><div class="para"> <p>Initial treatment with a low molecular weight <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span> is needed for 5 days.</p></div><span id="v45392115" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Edoxaban</span> should not be used if creatinine clearance is <span class='symbol'></span> 15 mL/minute (0.25 mL/s/m2).</p></div></td></tr><tr class="even"><td><span id="v45392118" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Rivaroxaban</span></p></div></td><td><span id="v45392120" class="anchor"></span><div class="para"> <p>15 mg twice a day for 21 days taken with food</p></div><span id="v45392121" class="anchor"></span><div class="para"> <p>Then 20 mg once a day taken with food</p></div></td><td><span id="v45392123" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Rivaroxaban</span> should not be used for DVT or PE if creatinine clearance is <span class='symbol'></span> 30 mL/minute (0.5mL/s/m<sup>2</sup>).</p></div><span id="v45392124" class="anchor"></span><div class="para"> <p>Dosage may be lowered to 10 mg once a day after 6–12 months of treatment.</p></div></td></tr><tr class="odd" tablehead2=""><td><p class="tableHead2"><span id="v45392128" class="anchor"></span><div class="para"> <p>Factor IIa (<span class="genericDrug" data-showrollover="false">thrombin</span>) inhibitor</p></div></p></td><td><span id="v45392130" class="anchor"></span><div class="para"> <p></div></td></tr><tr class="even"><td><span id="v45392133" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Dabigatran</span></p></div></td><td><span id="v45392135" class="anchor"></span><div class="para"> <p>150 mg twice a day</p></div></td><td><span id="v45392137" class="anchor"></span><div class="para"> <p>Initial treatment with low molecular weight <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span> is needed for 5 days.</p></div><span id="v45392138" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Dabigatran</span> should not be used for DVT if creatinine clearance is <span class='symbol'></span> 30 mL/minute (0.5mL/s/m<sup>2</sup>).</p></div></td></tr></tbody> <tfoot><tr><td colspan="3"><span id="v45392082" class="anchor"></span><div class="para"> <p>DVT = deep venous thrombosis; PE = pulmonary embolism.</p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div></div><div id="hiddentblcontents" style="display:none"></div><div id="hiddentblcontents" style="display:none"><div id='hidden_v55610275'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v14464272"></span> <div class="TableFullPage" id="v55610275"> <h3 class="title">Oral Anticoagulants</h3> <div class="tableWrapper"> <table> <thead><tr><th style='text-align:left' scope='col'><span id="v55610284" class="anchor"></span><div class="para"> <p>Drug</p></div></th><th style='text-align:left' scope='col'><span id="v55610288" class="anchor"></span><div class="para"> <p>Comments</p></div></th></tr></thead> <tbody><tr class="odd" tablehead2=""><td colspan="2"><p class="tableHead2"><span id="v55610293" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Factor Xa</span> inhibitors</p></div></p></td></tr><tr class="even"><td><span id="v55610296" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Apixaban</span></p></div></td><td><span id="v55610301" class="anchor"></span><div class="para"> <p>Dosage may be lowered after 6–12 months of treatment.</p></div></td></tr><tr class="odd"><td><span id="v55610304" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Edoxaban</span></p></div></td><td><span id="v55610309" class="anchor"></span><div class="para"> <p>Initial treatment with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span> is needed for 5–10 days.</p></div><span id="v55610310" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Edoxaban</span> should not be used if creatinine clearance is < 15="" ml/minute=""><span class='symbol'></span> 0.25 mL/second).</p></div></td></tr><tr class="even"><td><span id="v55610313" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Rivaroxaban</span></p></div></td><td><span id="v55610318" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Rivaroxaban</span> should not be used for DVT or PE if creatinine clearance is < 30="" ml/minute="">< 0.5="" ml/second).=""></p></div><span id="v55610319" class="anchor"></span><div class="para"> <p>Dosage may be lowered to 10 mg once/day after 6–12 months of treatment.</p></div></td></tr><tr class="odd" tablehead2=""><td colspan="2"><p class="tableHead2"><span id="v55610323" class="anchor"></span><div class="para"> <p>Factor IIa (<span class="genericDrug" data-showrollover="false">thrombin</span>) inhibitor</p></div></p></td></tr><tr class="even"><td><span id="v55610326" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Dabigatran</span></p></div></td><td><span id="v55610330" class="anchor"></span><div class="para"> <p>Initial treatment with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span> is needed for 5–10 days.</p></div><span id="v55610331" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Dabigatran</span> should not be used for DVT if creatinine clearance is < 30=""></p></div></td></tr></tbody> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div><div id="hiddentblcontents" style="display:none"><div id='hidden_v55610275'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v14464272"></span> <div class="TableFullPage" id="v55610275"> <h3 class="title">Oral Anticoagulants</h3> <div class="tableWrapper"> <table> <thead><tr><th style='text-align:left' scope='col'><span id="v55610284" class="anchor"></span><div class="para"> <p>Drug</p></div></th><th style='text-align:left' scope='col'><span id="v55610288" class="anchor"></span><div class="para"> <p>Comments</p></div></th></tr></thead> <tbody><tr class="odd" tablehead2=""><td colspan="2"><p class="tableHead2"><span id="v55610293" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Factor Xa</span> inhibitors</p></div></p></td></tr><tr class="even"><td><span id="v55610296" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Apixaban</span></p></div></td><td><span id="v55610301" class="anchor"></span><div class="para"> <p>Dosage may be lowered after 6–12 months of treatment.</p></div></td></tr><tr class="odd"><td><span id="v55610304" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Edoxaban</span></p></div></td><td><span id="v55610309" class="anchor"></span><div class="para"> <p>Initial treatment with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span> is needed for 5–10 days.</p></div><span id="v55610310" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Edoxaban</span> should not be used if creatinine clearance is < 15="" ml/minute=""><span class='symbol'></span> 0.25 mL/second).</p></div></td></tr><tr class="even"><td><span id="v55610313" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Rivaroxaban</span></p></div></td><td><span id="v55610318" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Rivaroxaban</span> should not be used for DVT or PE if creatinine clearance is < 30="" ml/minute="">< 0.5="" ml/second).=""></p></div><span id="v55610319" class="anchor"></span><div class="para"> <p>Dosage may be lowered to 10 mg once/day after 6–12 months of treatment.</p></div></td></tr><tr class="odd" tablehead2=""><td colspan="2"><p class="tableHead2"><span id="v55610323" class="anchor"></span><div class="para"> <p>Factor IIa (<span class="genericDrug" data-showrollover="false">thrombin</span>) inhibitor</p></div></p></td></tr><tr class="even"><td><span id="v55610326" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Dabigatran</span></p></div></td><td><span id="v55610330" class="anchor"></span><div class="para"> <p>Initial treatment with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>heparin</span> is needed for 5–10 days.</p></div><span id="v55610331" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Dabigatran</span> should not be used for DVT if creatinine clearance is < 30=""></p></div></td></tr></tbody> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div></body>
<div class="bottomnav__gotolink bottomnav__gotolink--next"></div>  <div class="fixed-footer fixed-width" align="right" id="setbackgrnd"><table class="fixed-width"><tr class="fixed-width"><td id="tdsearch" align="right" class="tdsearch"><input type="text" id="search" onkeyup="search(id)" placeholder="Find on page..." class="form-control search"></td><td id="tdbtn" align="left" class="tdbtn"><button onclick="myFunction()" id="button" class="button"></button></td></tr></table></div>
</html>